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ABSTRACT 
THE ASSESSMENT OF TECHNOLOGY ADOPTION INTERVENTIONS AND OUTCOME 
ACHIEVEMENT RELATED TO THE USE OF A CLINICAL RESEARCH DATA 
WAREHOUSE 
by 
Katie A. McCarthy 
The University of Wisconsin-Milwaukee, 2019 
Under the Supervision of Dr. Jake Luo 
Introduction:  While funding for research has declined since 2004, the need for rapid, 
innovative, and lifesaving clinical and translational research has never been greater due to the 
rise in chronic health conditions, which have resulted in lower life expectancy and higher rates of 
mortality and adverse outcomes.  Finding effective diagnostic and treatment methods to address 
the complex challenges in individual and population health will require a team science approach, 
creating the need for multidisciplinary collaboration among practitioners and researchers. 
To address this need, the National Institutes of Health (NIH) created the Clinical and 
Translational Science Awards (CTSA) program.  The CTSA program distributes funds to a 
national network of medical research institutions, known as “hubs,” that work together to 
improve the translational research process.  With this funding, each hub is required to achieve 
specific goals to support clinical and translational research teams by providing a variety of 
services, including cutting edge use of informatics technologies.  As a result, the majority of 
CTSA recipients have implemented and maintain data warehouses, which combine disparate data 
types from a range of clinical and administrative sources, include data from multiple institutions, 
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and support a variety of workflows.  These data warehouses provide comprehensive sets of data 
that extend beyond the contents of a single EHR system and provide more valuable information 
for translational research. 
Although significant research has been conducted related to this technology, gaps exist regarding 
research team adoption of data warehouses.  As a result, more information is needed to 
understand how data warehouses are adopted and what outcomes are achieved when using them.  
Specifically, this study focuses on three gaps:  research team awareness of data warehouses, the 
outcomes of data warehouse training for research teams, and how to measure objectively 
outcomes achieved after training.  
By assessing and measuring data warehouse use, this study aims to provide a greater 
understanding of data warehouse adoption and the outcomes achieved.  With this understanding, 
the most effective and efficient development, implementation, and maintenance strategies can be 
used to increase the return on investment for these resource-intensive technologies.  In addition, 
technologies can be better designed to ensure they are meeting the needs of clinical and 
translational science in the 21st century and beyond.   
Methods:  During the study period, presentations were held to raise awareness of data 
warehouse technology.  In addition, training sessions were provided that focused on the use of 
data warehouses for research projects.  To assess the impact of the presentations and training 
sessions, pre- and post-assessments gauged knowledge and likelihood to use the technology.  As 
objective measurements, the number of data warehouse access and training requests were 
obtained, and audit trails were reviewed to assess trainee activities within the data warehouse.  
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Finally, trainees completed a 30-day post-training assessment to provide information about 
barriers and benefits of the technology.    
Results:  Key study findings suggest that the awareness presentations and training were 
successful in increasing research team knowledge of data warehouses and likelihood to use this 
technology, but did not result in a subsequent increase in access or training requests within the 
study period.  In addition, 24% of trainees completed the associated data warehouse activities to 
achieve their intended outcomes within 30 days of training.  The time needed for adopting the 
technology, the ease of use of data warehouses, the types of support available, and the data 
available within the data warehouse may all be factors influencing this completion rate.   
Conclusion:  The key finding of this study is that data warehouse awareness presentations and 
training sessions are insufficient to result in research team adoption of the technology within a 
three-month study period.  Several important implications can be drawn from this finding.  First, 
the timeline for technology adoption requires further investigation, although it is likely longer 
than 90 days.  Future assessments of technology adoption should include an individual’s timeline 
for pursuing the use of that technology.  Second, this study provided a definition for outcome 
achievement, which was completion of activities within a data warehouse needed to achieve an 
intended research outcome as identified by the research team.  While this definition is a good 
baseline, it needs to be refined with input from research teams.  Finally, this study confirmed 
previous findings related to technology adoption, which indicated that time, ease of use, support, 
and data availability are important factors.  Additional work is needed to identify the significance 
and correlation of these factors with technology adoption. 
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This study provides important findings regarding attainment of technology knowledge and its 
links to actual technology use, the correlation between self-reported likelihood to use and actual 
technology use, the timeline of technology adoption, and foundational protocols for objective 
measurement of technology use and adoption.  Future research should focus on refining the 
objective measurement of “outcome achievement,” understanding the timing of technology 
adoption, and measuring the significance and correlation of factors influencing data warehouse 
use. 
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CHAPTER 1: INTRODUCTION 
In 2002, the United States (US) National Institutes of Health (NIH) announced development of 
the NIH Roadmap to accelerate research progress.1  In creating this roadmap, leaders identified 
three themes on which to focus national strategies regarding research acceleration:  New 
Pathways to Discovery, Research Teams of the Future, and Reengineering the Clinical Research 
Enterprise.1,2  One of the strategies to address the final theme was the launch of the Clinical and 
Translational Science Awards (CTSA) program.  Announced in October 2005, the program’s 
goals are to eliminate barriers between basic and clinical research, address the increasing 
complexities in conducting clinical research, and create academic homes for clinical and 
translational science.2   
Administered by the National Center for Advancing Translational Sciences (NCATS), the CTSA 
program distributes funds to a national network of more than 50 medical research institutions, 
also known as “hubs,” that work together to improve the translational research process.3,4  In 
fiscal year 2016, a total of more than $487 million was awarded to 57 CTSA hubs.4  With this 
funding, each hub is required to achieve five goals related to translational research.  One of these 
goals is to “advance the use of cutting-edge informatics.”3  In addition, a high priority is the use 
of information technology (IT) to integrate clinical research and clinical workflows,5 and the 
NIH has called for increasing the secondary use of electronic health record (EHR) data for 
clinical research purposes.6   
Based on these priorities, many CTSA hubs have implemented and maintain data warehouses, 
which are “’…subject-oriented, integrated, time-variant, non-volatile collection[s] of data…’ 
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[that address] data management, integration, and access issues.”7  According to a 2010 CTSA 
survey, 86% of respondents indicated that their organization had one or more data warehouses.8  
These data warehouses combine disparate data types from a range of clinical and administrative 
sources such as EHRs and registries and may include data from multiple institutions.8  The result 
is a comprehensive set of records that extends beyond the data contained within a single EHR 
and provides more valuable information for translational research. 
1.1 Research Problem and Overall Aims 
Although significant research is being conducted about and with data warehouses for current and 
future clinical and translational research purposes, critical gaps exist in the literature corpus and 
real-world implementation and practice.  First, little is known regarding the effectiveness of 
interventions in increasing researcher and research team awareness of data warehouses and their 
use in clinical and translational science.  Second, while CTSA hubs often provide data 
warehouse training for research teams, little is known about the effectiveness of this training and 
subsequent use of data warehouses.  Finally, a critical gap exists in defining objective measures 
for determining if research teams achieve their intended outcomes when using data warehouses.   
To study these knowledge gaps and identify areas that require new solutions, this study 
developed a presentation intervention to raise research team awareness of data warehouses and 
assessed and measured the outcomes of this intervention.  In addition, the study assessed and 
measured the outcomes of existing data warehouse training.  Finally, the study identified 
potential factors that influence the achievement of intended outcomes when using a data 
warehouse. 
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1.2 Study Conceptual Frameworks 
To achieve these aims, the study approach was based on the five innovation-decision stages 
(knowledge, persuasion, decision, implementation, and confirmation) identified in the Diffusion 
of Innovation (DOI) theory.9  In addition, the Technology Acceptance Model (TAM) and 
DeLone and McLean Information Systems Success Model were used to identify critical content 
for the awareness presentation intervention and existing training and to focus assessment on key 
aspects influencing technology adoption and acceptance.  Finally, the Bloom’s Taxonomy of 
Educational Objectives was used to correctly structure assessment items for the awareness 
intervention and training learning objectives.  The details of these frameworks are provided in 
Chapter 3: Conceptual Frameworks. 
1.3 Scope and Approach 
This research study was performed within the Clinical and Translational Science Institute (CTSI) 
of Southeast Wisconsin in collaboration with the CTSI Biomedical Informatics (BMI) 
department.  The CTSI BMI department provides a Clinical Research Data Warehouse (CRDW) 
that contains data from a variety of EHRs, clinical information systems, and registries, similar to 
data warehouses implemented by other CTSA hubs.  Subsequently, this study focused on the 
CRDW and its use as representative of similar data warehouses for clinical and translational 
research purposes.  Data for this study was collected through assessment tools, BMI databases, 
and CRDW audit trails.  The research questions and hypotheses, as well as specific aspects of the 
study’s methodology, design, and procedures are provided in Chapter 4: Methods. 
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1.4 Significance of the Study 
While funding for research has declined since 2004, the need for rapid, innovative, and 
lifesaving clinical and translational research has never been greater.10  In the US population, 
68% of adults age 65 or older have at least two chronic health conditions, and a third of adults 
are considered obese.11  In comparison to other developed countries around the world, the US 
has lower life expectancy, higher rates of mortality for ischemic heart disease, and higher rates of 
adverse outcomes from diabetes.11  Finding effective diagnostic and treatment methods to 
address the complex challenges in individual and population health will require a team science 
approach, creating the need for multidisciplinary collaboration among practitioners and 
researchers.12   
Individuals trained in biomedical informatics are uniquely suited for this research approach.  
Biomedical informaticists have competencies in the creation and application of models for 
biomedical data, information, and knowledge.13  In addition, they are expected to understand 
concepts and data that span the translational medicine spectrum (e.g., biology, clinical care, 
epidemiology, and health services).  Because integrating clinical and research data from diverse 
data sources and numerous multidisciplinary teams will be critical for cost-effective and efficient 
translational research, biomedical informatics approaches will be required “…to manage, 
organize, and integrate heterogeneous data to inform decisions from bench to bedside to 
community to policy.”12   
Although technologies have already been implemented to support this requirement, more 
information is needed to understand how these technologies are adopted and what outcomes are 
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achieved when using them.  By assessing and measuring the CTSI BMI CRDW adoption and 
use, this study aims to provide greater understanding of data warehouse adoption and the 
outcomes achieved.  With this understanding, the most effective and efficient development, 
implementation, and maintenance strategies can be used to increase the return on investment for 
these resource-intensive data warehouse technologies.  In addition, technologies can be better 
designed to ensure they are meeting the needs of clinical and translational science in the 21st 
century and beyond. 
1.5 Summary of Remaining Chapters 
This chapter provides an overview of the study aims and a summary of the research approach, 
scope, and significance.  Subsequent chapters provide the following information: 
 Chapter 2: Literature Review provides the basis for the research aims, as well as the potential 
contribution of this study to the existing literature corpus. 
 Chapter 3: Conceptual Frameworks identifies the theoretical models used to design the study 
components within this research project. 
 Chapter 4: Methods describes the research questions, design, hypotheses, and associated 
study components; the CTSI and associated target population; and project elements such as 
timeline and budget. 
 Chapter 5: Results provides the study findings, including the acceptance or rejection of each 
of the study’s hypotheses. 
 Chapter 6: Discussion reflects on the findings based on the study’s research questions and 
outlines future research opportunities. 
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CHAPTER 2: LITERATURE REVIEW 
The focus of this research study is the use of data warehouses for clinical and translational 
research.  This chapter describes several areas within literature that informed this study.   
 Section 2.1, The National Institutes of Health (NIH), provides an overview of the NIH, its 
role in the creation of the CTSA program, and the need for biomedical informatics within this 
program.   
 Section 2.2, Use of Electronic Health Record Data for Research, describes the use of EHRs 
within research, including the challenges that have led to the development and 
implementation of data warehouses (integrated data repositories).   
 Section 2.3, Summary of Research Themes in Current Literature, summarizes the literature 
relating to data warehouses and their uses for research purposes.   
 Section 2.4, Importance of Data Warehouses in Future Research, outlines key areas of future 
research requiring the use of data warehouses and associated skills.   
 Section 2.5, Key Gaps Within Existing Literature, identifies the key gaps that exist within the 
literature corpus related to data warehouses and their use for clinical and translational 
research.   
2.1 The National Institutes of Health (NIH) 
In 1887, the NIH began as a one-room laboratory within the Marine Hospital Service (MHS), the 
predecessor agency to the US Public Health Service (PHS).14,15  Since then, the NIH has grown 
to include 27 institutes and centers, including the National Cancer Institute (NCI), the National 
Library of Medicine (NLM), the National Human Genome Research Institute (NHGRI), and the 
NCATS.16  With funding of more than $32 billion in fiscal year 2016, the NIH has become the 
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world’s largest funder of biomedical research, supporting more than 300,000 scientists and 
technical personnel working at more than 2,500 universities, hospitals, medical schools, and 
other research institutions in the US and throughout the world.17,18  Supported by this funding, 
research advances have led to increased average life expectancies for Americans, reductions in 
disability rates, and reductions in all-cause mortality rates, including rates due to cardiac disease, 
diabetes, stroke, and cancer.2,17  Overall, NIH-supported research has been a primary source of 
new discoveries, drugs, devices, and clinical procedures that have contributed to the health and 
longevity of individuals and populations around the world, resulting in more than eighty Nobel 
prizes.10,15  The following subsections describe the development of the NIH roadmap to 
accelerate research, the subsequent creation of the CTSA program, and the need for biomedical 
informatics within CTSA hubs. 
2.1.1 Development of the NIH Roadmap 
Supporting this type of research has not been without challenges, especially in the early 2000s.  
During that time, the US faced deep federal and trade deficits, increased spending for homeland 
security, and unexpected economic and financial devastation from natural disasters such as 
Hurricane Katrina.2  From a population perspective, the US faced an aging population suffering 
from predominantly chronic diseases, as well as emerging public health challenges in the form of 
obesity and diabetes.2  Within the scientific research community, costs were rising, yet funding 
was beginning to decrease after years of increases.1,2  By 2004, NIH funding reached its peak, 
and then began to decline nearly 2% per year, resulting in a 13% decrease in NIH purchasing 
power.10  In response to these challenges, the NIH needed to devise a strategy to improve the 
return on its investment by reducing costs and refocusing the clinical research enterprise. 
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Beginning in 2002, the NIH began working on the “NIH Roadmap” with the goal of defining a 
set of limited priorities that could lead to the acceleration of research across the institute 
missions.1  As a national clinical research enterprise, several key challenges needed to be 
addressed in this roadmap.  First, research study participants would need to increase in number 
and diversity (such as by gender, age, and ethnicity) to support the speed of discovery.  
Encouraging public participation would require addressing concerns related to conflicts of 
interest, safety, and privacy.19  Second, information systems would need to be developed and 
implemented to support effective and efficient data capture, maintenance, and retrieval.  
Addressing this challenge would require creation of data and exchange standards, as well as 
educational programs to produce a qualified workforce in biomedical informatics.19  Third, 
accelerating the rate of research requires an adequately trained workforce of many kinds of 
investigators such as clinicians, basic scientists, computer programmers, and engineers who can 
work together on the complex issues facing health and healthcare.  Funding sources and 
programs would need to be created to support the work of young researchers, as well as 
incentivize multidisciplinary projects.19  Finally, overall funding (government, industry, and 
foundations) would need to increase to support the identified initiatives.19 
After consulting more than 300 of the nation’s biomedical leaders from academia, government 
organizations, and industry regarding these challenges, three themes emerged and became the 
foci for the NIH Roadmap:  New Pathways to Discovery, Research Teams of the Future, and 
Reengineering the Clinical Research Enterprise.1,2  The New Pathways to Discovery theme 
focuses on initiatives to address the technologies and approaches necessary to understand 
complex biological systems and address contemporary research issues such as building blocks 
and pathways, molecular imaging, bioinformatics, computational biology, and structural 
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biology.1  The Research Teams of the Future theme focuses on the creation of new team science 
organizational models that provide mechanisms for high-risk strategies, interdisciplinary 
research, and public and private research partnerships.1  Finally, the Reengineering the Clinical 
Research Enterprise theme focuses on creating integrated networks of academic centers and 
communities to support clinical trials and research, as well as creating the training programs and 
informatics infrastructure necessary to make these networks effective, efficient, and trustworthy.1 
2.1.2 Creation of the CTSA Program 
Once identified, these themes were translated into specific NIH awards and initiatives. In fiscal 
year 2005, for example, the roadmap initiatives resulted in 345 individual awards at 133 
institutions in 33 states.2  One of the initiatives related to the Reengineering the Clinical 
Research Enterprise theme was the development of the CTSA program.  Announced in October 
2005, the program’s goals are to eliminate barriers between basic and clinical research, address 
the increasing complexities in conducting clinical research, and create academic homes for 
clinical and translational science.2  The program focuses on translational research, which has two 
approaches.  The first, known as “bench-to-bedside” research, is the translation of laboratory 
discoveries to clinical practice with the end goal of new treatments that can be used clinically or 
commercially.8,20  The second, known as health services research, is the translation of research 
and treatments into practice, making sure that these interventions reach the patients and 
populations for whom they are intended as well as using clinical practice to inform new studies.  
This type of translational research looks to improve the quality of care by increasing access, 
coordinating systems of care, providing information and decision support for clinicians, and 
strengthening the patient-provider relationship.8,20,21  With new knowledge about disease having 
10 
a 15- to 25-year gestation from basic discovery to clinical application and most research being 
adopted by only 50% of clinicians within 17 years, the need to accelerate both forms of 
translational research is critical to addressing current and future challenges in health and 
healthcare.10,22 
Administered by NCATS, the CTSA program distributes funds to a national network of more 
than 50 medical research institutions, also known as “hubs,” that work together to improve the 
translational research process.3,4  For example, in fiscal year 2016, a total of more than $487 
million was awarded to 57 institutions through the CTSA program.4  With this funding, each hub 
is required to achieve the following CTSA program goals:  
 “Train and cultivate the translational science workforce. 
 Engage patients and communities in every phase of the translational process. 
 Promote the integration of special and underserved populations in translational research 
across the human lifespan. 
 Innovate processes to increase the quality and efficiency of translational research, 
particularly multisite trials. 
 Advance the use of cutting-edge informatics.”3 
2.1.3 Need for Biomedical Informatics within CTSA Hubs 
Since the inception of the CTSA program, the NIH has recognized “… the critical need to apply 
biomedical informatics theories and methods to enable the collection, exchange, management, 
analysis and dissemination of multidimensional datasets and knowledge collections.”23  As 
defined by the American Medical Informatics Association (AMIA), “biomedical informatics 
11 
(BMI) is the interdisciplinary field that studies and pursues the effective uses of biomedical data, 
information, and knowledge for scientific inquiry, problem solving, and decision making, driven 
by efforts to improve human health.”13  Although biomedical informaticists will typically 
specialize in one or more application domains such as biology (bioinformatics), clinical care 
(clinical informatics), research processes (research informatics), or public health (public health 
informatics), the BMI core competencies have broad applicability inside and outside of 
biomedicine.24  In addition to fundamental scientific skills such as problem definition, data 
analysis, solution generation and implementation, collaboration, and discussion and 
dissemination of ideas, such core competencies include familiarity with biological, biomedical, 
and health concepts and problems; creation and application of models for biomedical data, 
information, and knowledge; knowledge of data structures, algorithms, programming, 
mathematics, and statistics; and understanding and application of the fundamentals of social, 
organizational, cognitive, and decision sciences.13   
Proficiency in these core competencies makes biomedical informaticists uniquely suited for 
translational research.  Because integrating clinical and research data is critical for cost-effective 
and efficient translational research, BMI approaches are required “…to manage, organize, and 
integrate heterogeneous data to inform decisions from bench to bedside to community to 
policy.”12  Additionally, achievement of translational innovations requires a team science 
approach, creating the need for multidisciplinary teams of practitioners and researchers to 
conduct studies.12  Because biomedical informaticists are expected to understand concepts that 
span the translational medicine spectrum (e.g., biology, clinical care, epidemiology, and health 
services), they have the ability to interact and communicate effectively with a variety of team 
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members, as well as serve as translators for the entire team.12  Subsequently, BMI expertise and 
resources are critical for CTSA hubs to achieve program goals.23 
2.2 Use of Electronic Health Record Data for Research  
For most CTSA hubs, BMI programs have focused on informatics training, database 
design/hosting, data warehouses, data sharing infrastructure, and complex data analyses.23  
Among these activities, a high priority is the use of IT to integrate clinical research and clinical 
workflows.5  In addition, the NIH has called for increasing the secondary use of EHR data for 
clinical research purposes.6  Based on these priorities, BMI programs began to focus on the use 
of existing data sources, specifically EHRs, for clinical and translational research purposes.  The 
following subsections describe the impact of government incentives on the rate of EHR adoption, 
the challenges in using EHR systems for research purposes, and the creation of data warehouses 
to address these challenges. 
2.2.1 Impact of Government Incentives on EHR Adoption 
Although EHRs contain a wide array of clinical data that have tremendous potential for 
comparative effectiveness and outcomes research, direct use of this data has proven 
problematic.25 One initial challenge was the low adoption rate of health information technology 
(HIT) and EHRs.  In 2008 (just two years after the first CTSA hubs received funding), less than 
10% of non-federal acute care hospitals had adopted basic EHRs that allowed entry and retrieval 
of patient demographics; problem lists; medication lists; medication orders; discharge 
summaries; and lab, radiology, and diagnostic test results.26  While researchers estimated that 
adopting EHRs could result in saving more than $77 billion annually, the adoption of HIT was 
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modest compared to other industries and showed little sign of increasing significantly.27  
Recognizing the need to reengineer the way healthcare data are collected, stored, and used, the 
US government passed the Health Information Technology for Economic and Clinical Health 
(HITECH) Act in 2009.28  Part of the American Recovery and Reinvestment Act (ARRA) of 
2009, the HITECH Act set aside $29 billion over ten years to support the adoption of EHRs.28  A 
key component of this legislation was incentive payments for eligible professionals and hospitals 
that demonstrated meaningful use of these EHRs.29  By 2015, these incentives resulted in more 
than $20.9 billion in payments to professionals and hospitals.30  In addition, 96% of non-federal 
acute care hospitals possessed EHR technology, with almost 84% of these hospitals having 
implemented basic EHR functionality.26  
2.2.2 Challenges in Using EHR Systems for Research Purposes 
While the HITECH Act has increased the adoption of EHRs, EHR systems and underlying 
databases are not structured for research purposes, which poses inherent challenges when 
attempting to use EHR systems for capturing, storing, and retrieving research data. While some 
organizations have been successful in configuring EHRs for both clinical and research 
purposes,31 most have struggled to overcome basic conflicts between the information and 
workflow needs of clinicians and researchers.25   
One fundamental issue is that EHR systems are optimized to quickly store and retrieve 
information based on a single patient, while research requires querying data over multiple 
patients.32  Within some EHR systems, only limited functions may be available to construct 
multi-patient queries and/or these queries may require significant time to complete.   
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Additionally, EHR system contracts may create problematic organizational boundaries.  
Generally, the purchase, implementation, and maintenance of an EHR system is governed by a 
contract between the EHR vendor and the purchaser.  Contractual terms may limit the number of 
licenses that can be used to access the EHR and/or the organizations that may enter data within 
the system.  The result is an EHR system that includes information for a single healthcare 
organization, while research may require data from multiple institutions.25   
A third issue is that EHR systems are designed to capture unstructured, narrative data that 
involve no or a minimally specified data model.  While EHR systems may include some data 
rules and validation (such as not allowing entry of birthdates with a year 1800 or limiting entries 
to a defined list of options), a significant amount of EHR data cannot be validated by the system, 
nor do most systems provide a significant number of features for data validation and analysis.  In 
contrast, research databases often involve well-defined and structured data in discrete fields to 
allow the system-supported validations and analyses required to answer specific research 
questions.25   
Finally, most EHR systems capture data such that clinicians are not required to clean or 
transform data prior to its use in clinical contexts.  As a result, most EHR systems lack the 
necessary functions and features to perform the type of data cleaning and/or transformation 
required for research purposes.  In addition, even if these features were provided within an EHR 
system, performing data cleaning and/or transformation within the primary clinical database 
could prove harmful to patient care if done incorrectly.32 
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In an attempt to address these challenges, EHR system vendors have developed functions and 
features to allow organizations to share their EHR systems with partners (such as independent 
physician groups) and to extract EHR data into databases specifically for reporting purposes.  
Unfortunately, these advancements do not address the lack of an underlying data model in the 
originating system, nor the need for competing health systems to participate in the same research 
project.  As a result, CTSA hubs have investigated alternative approaches for using EHR data 
within translational research. 
2.2.3 Creation of Data Warehouses for Research 
In response to these challenges, many CTSA hubs have implemented and maintain data 
warehouses (also known as integrated data repositories), which are “’…subject-oriented, 
integrated, time-variant, non-volatile collection[s] of data…’ [that address] data management, 
integration, and access issues.”7  For example, according to a 2010 CTSA survey, 86% of 
respondents indicated that their organizations had one or more data warehouses.8  These data 
warehouses combine disparate data types from a range of clinical and administrative sources 
such as EHRs and registries and may include data from multiple institutions.8  Additionally, 
instead of being built to only support one workflow (such as clinical care), data warehouses 
typically support a range of heterogeneous users including researchers, clinicians, and 
administrators.8  From a data quality perspective, data warehouses can store metadata from each 
of the originating systems that explain the context in which the data were captured and their 
meaning, which increases the likelihood of correctly translating the data.  Because these data 
warehouses also contain data from multiple sources, researchers can access more complete 
information for an individual patient (such as having access to records from multiple hospitals 
16 
for a single patient) and/or link clinical information with financial, utilization, and quality data to 
verify consistency of records (such as ensuring that gynecological exams were only conducted 
on biologically female patients).33  The result is a more comprehensive set of data that extends 
beyond the contents of a single EHR system and provides more valuable information for 
translational research. 
2.3 Summary of Research Themes in Current Literature 
The creation of data warehouses for clinical and translational research has resulted in studies 
related to their development and implementation.  In addition, clinical researchers have begun to 
publish studies based on the use of EHR and other data from these data warehouses.  Finally, 
another category of literature relates to improving data warehouses for research purposes.  The 
following subsections provide examples of these studies and summarize the key findings. 
2.3.1 Data Warehouse Development and Implementation 
Literature focusing on data warehouse development and implementation provides insight into the 
benefits and challenges of implementing these platforms.  Common themes include the creation 
of a common data model and/or mapping that can be used to transform data from local systems 
into the data warehouse; technical architectures that can be scaled to integrate data from a variety 
of sources; and the need to protect patient privacy while reducing regulatory burden.  Below are 
several examples of data warehouse projects described in the literature that represent these 
themes. 
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The Observational Health Data Sciences and Informatics (OHDSI) program is “an international 
collaborative whose goal is to create and apply open-source data analytic solutions to a large 
network of health databases to improve human health and well-being.”34  Coordinated through a 
center housed at Columbia University, the OHDSI team of academics, industry scientists, health 
care providers, and regulators have developed a common data model that can be used to 
transform databases into a common format that can be centralized into a single data warehouse 
for research purposes.34,35 Once transformed into this structure, researchers can apply the open 
source analytic tools for data exploration (ATLAS), data quality assessment (ACHILLES), 
feasibility assessment (CALYPSO), and drug exposure visualization (DRUG EXPOSURE 
EXPLORER) that have been developed by OHDSI.34,35 Additionally, researchers can join the 
OHDSI research network and collaborate on research projects.35  Continued development of this 
platform will support observational studies that inform clinical practice using the unprecedented 
amount of patient data currently available.34 
European researchers have developed the Electronic Health Records for Clinical Research 
(EHR4CR) project, which is “…an innovative platform capable of transforming conventional 
clinical research processes by enhancing protocol feasibility assessment, patient identification for 
recruitment, and clinical data exchange.”36  Funded by the European Commission and the 
European Federation of Pharmaceutical Industries and Associations (EFPIA), the EHR4CR 
project involves 34 academic and private partners working together with the goal of developing 
adaptable, reusable, and scalable solutions for reusing EHR data for research purposes.36,37  The 
platform is based on a Service Oriented Architecture (SOA) that allows service providers and 
consumers to dynamically connect to the platform through clearly defined interfaces.37  Data 
from clinical data warehouses or EHRs at local sites are interfaced and mapped to the EHR4CR 
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database and then provided through different services to the end user.37  These services are 
focused on particular use cases such as querying of eligibility criteria, recruiting patients, and 
mapping terminology.37  Security is maintained through implementation of standards such as 
SOAP (web service interactions), WS-Security (secure messaging), WS-Trust (relationship 
brokering), and SAML (end user authentication).37  As a result of this work, the European 
Institute for Innovation through Health Data (i~HD) has been formed to guide and catalyze 
“…the best, most efficient and trustworthy uses of health data and interoperability for optimizing 
health and knowledge discovery.”38 
The Oncoshare project was founded in 2008 as a collaboration among Stanford University, the 
Palo Alto Medical Foundation, and the Cancer Prevention Institute of California with the goal of 
developing a shared database for translational research and outcomes analysis specifically for 
women treated for breast cancer.39,40  This shared data warehouse integrates data from registries, 
EHRs, genomic sequencing laboratories, and patients, providing the necessary breadth and depth 
to identify care pathways that provide the best outcomes for patients.39,40  To create this 
integration, records that meet the inclusion criteria are transformed into a standard data model 
and then aggregated into a shared, anonymized data warehouse.39  From this data warehouse, 
researchers can create data marts that are specific to their particular research questions.39  These 
data marts contain a subset of data from the data warehouse and are focused on a specific 
research question or subject area.41  The Oncoshare project has resulted in more than 20 
publications and presentations, and ongoing research continues with funding from the NCI and 
the NIH CTSA program, among others.40 
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In 2008, the NIH Clinical Center established a data warehouse known as the Biomedical 
Translational Research Information System (BTRIS), which contains data on over 500,000 
research subjects.42  While researchers can extract both de-identified and identified data from the 
BTRIS, practical and administrative challenges exist related to patient privacy regulations.42  
Because one approach to reducing this regulation is to use data from deceased patients, 
researchers from the NIH Clinical Center used BTRIS to identify deceased patients and extract 
them into a separate data warehouse.42  While continued work is needed to clarify the regulatory 
guidance for de-identifying decedent records and to determine the effect of bias that may exist 
(such as having a proportionately larger number of older, sicker patients than the BTRIS), a data 
warehouse consisting of deceased patient records could prove an important tool to reduce 
regulatory burden when accessing data for research purposes.42 
2.3.2 Use of Data from EHRs and Data Warehouses 
Literature also exists that describes the results of using data from EHRs and data warehouses for 
clinical and translational research purposes.  One category of literature addresses the ability to 
more effectively and efficiently perform research tasks such as cohort identification and 
feasibility assessment using data warehouses when compared to traditional methods.  A second 
category includes literature that attempts to replicate clinical research through use of a data 
warehouse.  While these studies have identified efficiency gains and some ability to replicate 
results, caution is advised when considering a complete replacement of traditional methods with 
data warehouse supported methods.  Below are several examples from the literature of these 
types of research studies. 
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Based on EHR data, Mayo Clinic researchers compared two methods for prospective recruitment 
of patients with heart failure – one using natural language processing (NLP) and one using 
predictive modeling – to traditional methods that rely on coding information.43  Reliance on 
coding information is problematic for some diseases, such as heart failure, which cannot be 
diagnosed with a single test and may have a variety of symptoms due to its syndromic nature.43  
In addition, coding is a manual process that introduces delays in identifying patients for 
recruitment.  To find a more effective and efficient process for prospective recruitment, 
researchers developed algorithms for these two approaches and applied them to EHR clinical 
notes.  They found that the NLP algorithm identified all the heart failure patients that could be 
identified by the traditional coding approach, but also identified additional cases that the 
traditional approach had not identified, which could be helpful as a screening mechanism for 
observational studies.43  The predictive modeling algorithm had a positive predictive value of 
82%, which indicates a high likelihood of identifying patients that truly have heart failure, 
making this method a good screening mechanism for clinical trial inclusion and exclusion 
criteria.43  A key benefit of using these screening mechanisms is that they rely on clinical notes, 
which are typically available more quickly than traditional coding; thus, researchers can identify 
patients more quickly for participation in research studies.43    
Using the EHR4CR platform, researchers performed a cost-benefit analysis (CBA) to assess the 
value of the EHR4CR compared to current research processes for hypothetical Phase II and 
Phase III oncology trials.36  Three scenarios were analyzed:  protocol feasibility assessment, 
patient identification for recruitment, and clinical study execution.36  In performing this analysis, 
researchers found that using EHR4CR would translate into faster time to market (20% reduction 
in average cycle time) and reduced resources and costs (50% reduction in person time and 
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costs).36  Using the EHR4CR platform, these benefits were achieved through reducing the efforts 
required for refinement of inclusion and exclusion criteria, accelerating patient recruitment, and 
optimizing clinical trial execution.36 
Researchers in the United Kingdom (UK) used a comprehensive longitudinal electronic clinical 
database, the UK General Practice Research Database (GPRD), to replicate a set of six 
previously completed randomized controlled trials related to cardiovascular drug treatments.44  
The GPRD is a data warehouse that contains over eight million patient records from a 
representative sample of 5.7% of the UK population from 1990-2000.44  While some limitations 
were identified, such as missing or limited lab results, vitals, and history, the results of this work 
suggested that “…observational studies using databases might produce valid results concerning 
the efficacy of cardiovascular drug treatments.”44 
2.3.3 Improvement of Data Warehouses for Research Purposes 
Although literature contains examples of the benefits of using data warehouses for clinical and 
translational studies, considerable challenges exist before data warehouses are optimized for 
research purposes.  Broadly, these challenges involve data quality, data models and standards, 
data structure, and ethical and legal considerations.  Below is a summary of these challenges and 
the work being done to improve data warehouses. 
Data quality is one of the most significant challenges in the use of data warehouses for research 
purposes, in part because the concept of data quality is multi-dimensional and lacks a commonly 
accepted definition.45–48  Within the literature, the concepts of accuracy and completeness are 
most often used in data quality descriptions.45–47,49–55  Accuracy, which can be defined as the 
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extent to which data conform to the truth, often relies on correct and careful documentation, 
which can be challenging in a busy patient care setting.45,55  The result can be wrong diagnoses 
on a problem list, inclusion of documentation for two patients within the same record, and 
implausible documentation of services (such as gynecological services for biologically male 
patients).46,55  The definition and measurement of data quality concepts, though, can be context 
dependent, meaning that data considered high quality for one use may be considered poor quality 
for another use.48  For example, completeness in a clinical setting may be defined as 
documenting all of the observations from a patient encounter, while completeness when reusing 
this same data for research purposes may be defined as containing all the data elements 
necessary for the research study.6,49,55–58  Without a standard definition of data quality, efforts to 
improve data warehouses will produce marginal results, if any.  In addition, perceptions of poor 
data quality could prove to be a significant barrier in the adoption of data warehouses in clinical 
and translational research.  To address this challenge, current research focuses on identifying 
frameworks and ontologies for data quality45–47,52 and assessing data quality using these 
tools.56,57,59  
Additionally, the lack of a single, accepted data model for clinical and translational research has 
hampered interoperability across institutions and countries.60  As a simple example, a laboratory 
test such a comprehensive blood count (CBC) can be coded as a CBC in one system and code 
1568 in another system.  When attempting to integrate laboratory tests into a single data 
warehouse, they must to be mapped to a single, common concept.  Without this mapping, a 
researcher would need to know to use CBC and 1568 as codes to extract CBC results, which is 
an unrealistic expectation and likely to cause data to be missing from the data extraction.  To 
address this challenge, various international certification and standards bodies continue to pursue 
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the goal of creating the necessary models and standards.  Once identified, significant work will 
be required to implement these standards in EHRs, registries, and other data sources so that the 
overhead of transforming and mapping these data into data warehouses can be reduced.60 
From a data structure perspective, a significant portion of data from clinical sources is 
maintained within unstructured narratives, such as admission notes, treatment plans, and patient 
summaries.60  While abundantly available, this type of data is computationally the most difficult 
to analyze due to its heterogeneous nature; lack of conformity with grammar and sentence 
structures; and use of abbreviations, acronyms, and idiosyncratic language.60  Additionally, 
information may be duplicated within the data structure, making it difficult to determine if these 
are new findings or a restatement of existing findings.59  For example, a clinical note may 
include a statement of a concerning trend in high blood pressure readings that is already captured 
within the vitals data fields as discrete data.  While the discrete data may be easier to manage 
computationally, the clinical note may provide the most relevant information for a particular 
research study.  To address this challenge, current research focuses on optimizing NLP 
algorithms for automated coding of this data into more discrete forms and configuring EHRs 
such that data can be used for clinical and research purposes.31,43 
Legally and ethically, organizations that capture, store, and retrieve patient information have a 
duty to ensure the privacy of this data, a task that is particularly challenging in the age of 
numerous security breaches to IT systems.  To overcome this challenge, de-identification is often 
used within data warehouses, but the lack of identifiers can reduce the value of the data for 
research purposes.60  Additionally, researchers need to ensure appropriate consent was obtained 
for the data included within the warehouse, which can create a significant administrative burden 
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and potential bias in the patient population included.60  Without this consent, public trust in the 
research community can erode and this, in turn, can hinder public good.61  To encourage 
participation in studies, researchers must have a trustworthy process for obtaining consent and 
maintaining privacy.  To address these challenges, researchers are evaluating the use of data 
from deceased patients as a potential alternative.42  In addition, the 21st Century Cures Act 
includes provisions to improve privacy protections for research volunteers.62 
2.4 Importance of Data Warehouses in Future Research 
As the quality of data warehouses continues to improve based on these studies, competency in 
using data warehouses will be a critical skill for research teams participating in clinical and 
translational research.  Future research in genomics, precision medicine, and big data analytics 
will require use of large datasets containing diverse data from a variety of sources.  The 
following subsections describe the promise of future research in these areas, the role of data 
warehouses and large datasets within these research areas, and the need for research teams to 
demonstrate the necessary skills for taking advantage of these resources. 
2.4.1 Genomics 
From a classical Mendelian perspective, organisms contain genes that are inherited, and these 
genes define a variety of observable traits depending on gene dominance.63  The goals of the 
human genome project are to identify 100,000 different genes in humans and understand their 
expression and function.63  Researchers involved in this project and related research “…study 
genes, their interactions, their mutations, and the relationships they reveal between normal 
function and disease.”63  To achieve this understanding, research teams need genomic data 
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(typically, genome sequences), as well as phenotypic (clinical) data for individual patients and 
populations.64  A key challenge is the development of a system to house these two distinctly 
different types of data. 
While effectively integrating genomic data into EHRs remains a goal for vendors and health care 
systems, one of the key existing features of data warehouses is the ability to integrate data from a 
variety of sources.  As a result, a successful data warehouse implementation can be seen as a 
precondition for integrating clinical and genomics data.65  To drive the development of more 
accurate classifications of diseases and to enhance diagnosis and treatment methods, research 
teams will need “a data network that integrates research data on the molecular makeup of 
diseases with clinical data on individual patients….”65  Such a data warehouse will need to 
include appropriate storage of this data; a framework that enables scientists and researchers to 
explore the data and generate hypotheses; and information from other databases and data sources 
for cross-referencing.65 
Effective use of this data warehouse will require “…better integration of genomics and 
biomedical informatics into curricula for clinical researchers and providers.”63  Researchers and 
clinicians will need to participate in the development of standards and models for capturing and 
storing this information, as well as serve as advocates in debates related to the perplexing ethical, 
social, and economics issues that will occur when this data is integrated into a single platform.63  
Active and informed participation will require experience with capturing, storing, and retrieving 
data from a data warehouse to effectively represent the benefits and challenges of using such a 
technology. 
26 
2.4.2 Precision Medicine 
In his January 2015 State of the Union Address, President Barack Obama announced the 
Precision Medicine Initiative (PMI), which is meant to bring together clinical, genomic, 
environmental, lifestyle, and other related data to provide a comprehensive view of a patient’s 
state over time and customize disease prevention, detection, and treatment based on the 
individual patient.66–68  While individual variability (such as blood type) has been considered 
within some medical treatments, this initiative calls for a broad, evidence-based approach using 
innovative tools (such as mobile health technologies), large-scale biologic databases (such as the 
human genome sequence), powerful patient characterization methods (such as proteomics, 
metabolomics, and genomics), and computational tools for analyzing large sets of data to 
customize treatment and prevention and improve the overall effectiveness and quality of patient 
care.67,68   
In 2016, the 21st Century Cures Act was passed, which provides funding for PMI-related 
initiatives, among other initiatives.62,69  Worth $4.8 billion over ten years (starting in fiscal year 
2017), this funding will provide the NIH “…with critical tools and resources to advance 
biomedical research across the spectrum from basic, curiosity-driven studies to advanced clinical 
trials of promising new therapies.”62,69  Initiatives funded by this Act are meant to reduce 
administrative burdens that slow the progress of science, enhance data sharing and privacy 
protections for study participants, improve support for the next generation of biomedical 
researchers, and ensure the inclusion of diverse populations in clinical research.62,69  
Additionally, support is provided for four highly innovative scientific initiatives:  the All of Us 
Research Program, the Brain Research through Advancing Innovative Neurotechnologies 
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(BRAIN) Initiative, the Cancer MoonshotSM, and the Regenerative Medicine Innovation 
Project.62 
The All of Us Research Program, formerly known as the PMI Cohort Program, is a longitudinal 
cohort study meant to involve one million or more Americans who volunteer to provide biologic 
specimens (e.g., cell populations, proteins, and genome sequences); clinical data from EHRs; and 
lifestyle and behavioral information.67–69 This information will be used to create a 
“..transformative research infrastructure that will enable and simplify research across all 
diseases.”67,69 
The goal of the BRAIN Initiative is to understand how the brain functions, which will inform 
efforts to transform the ways in which neurological and mental disorders are diagnosed and 
treated.62  The initiative will focus on building technology and knowledge across disciplines to 
understand how circuits in the brain function in real time and what goes wrong when disease 
occurs.69 
The Cancer MoonshotSM will accelerate cancer research to improve prevention, detection, and 
treatment.70  The goal is “…to double the rate of progress in the fight against cancer, making 
more therapies available to patients, while also improving [the] ability to detect and prevent 
cancer.”69 
Finally, the Regenerative Medicine Innovation Project is coordinated through the NIH and the 
Food and Drug Administration (FDA) and supports clinical research using adult stem cells to 
further the field of regenerative medicine.62  Regenerative medicine is a field of science focusing 
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on the use of stem cells and other technologies to repair or replace damaged cells, tissues, or 
organs.71 
All of these initiatives will require the collection, storage, and retrieval of multi-parametric data 
from a variety of sources.72  Dedicated efforts will be required to integrate the multidimensional 
data from EHRs, large-scale genomic-wide data, and information from mobile health 
technologies into a single data warehouse to support the analytic and bioinformatics needs of 
clinicians and reseachers.33  Recently, to achieve this goal, the National Academy of Sciences 
(NAS) has called “…for the development of an information commons (IC) that amasses medical, 
molecular, social, environmental, and health outcomes data for large numbers of individual 
patients.”73  Effective use of such an IC or data warehouse will require changes to the training 
and education models for clinicians and researchers to include competencies related to 
quantitative reasoning, ability to access just-in-time information, and practice integrating 
multiple parameters for a holistic view of the patient and/or disease.66,68,72 
2.4.3 Big Data and Analytics 
Big data refers to complex datasets that challenge traditional data management systems due to 
the high volume of data, the diversity of the data within the dataset, and the rapid rate at which 
the data changes.74–76  Within healthcare, the adoption of EHR systems, digitization of medical 
images and videos, as well as other related information has resulted in an estimated 150 exabytes 
(150 billion gigabytes) of data in the US healthcare system by 2011.77  Should current growth 
rates continue, big data in healthcare will reach zettabytes (1021 gigabytes) or yottabytes (1024 
gigabytes).   
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To effectively gain information from this data, scientists apply analytics methods.  These 
methods include “…the use of mathematical and algorithmic processing of data resources, as 
well as techniques such as text mining and natural language processing, and visual analytics to 
generate descriptive, predictive, and prescriptive models to analyze and derive insight from 
data.”75  Application of these methods represents a significant opportunity for health care 
delivery systems, researchers, and clinicians.  Currently, clinical operations are estimated to 
include $165 billion in waste, which could be reduced by applying big data analytics to 
determine the most clinically relevant and cost-effective ways to diagnose and treat patients.77  
Additionally, health systems could use analytics to identify the estimated 5% of patients that 
account for 50% of all US health care spending and determine interventions to reduce these costs 
while maintaining the quality of care.76  Research and development is estimated to include $108 
billion in waste that could be reduced by using predictive modeling to produce leaner, faster, and 
more targeted research for drugs and devices, as well as improve design of clinical trials.77  
Application of these methods will also be required to effectively use the data gathered by the 
initiatives identified within the 21st Century Cures Act.69,74  Finally, clinicians need efficient and 
effective ways to apply the latest evidence in their practices, and big data analytics can be used to 
better predict disease for and match treatments to individual patients.77  From a public health 
perspective, these methods are already being applied by the Centers for Disease Control and 
Prevention (CDC) to inform clinicians about the spread of influenza.74 
To participate in the use of big data analytics, research teams will need to be versed in 
informatics, as well as their chosen disciplines.75,78  Using technologies like data warehouses can 
provide valuable experiences in applying informatics concepts to their existing research interests.  
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Additionally, experience leveraging this technology can improve the effectiveness and efficiency 
with which technologies are adopted within research programs.75 
2.5 Key Gaps Within Existing Literature 
Although significant research is being conducted about and with data warehouses for current and 
future clinical and translational science purposes, critical gaps exist within the literature corpus. 
First, little is known regarding interventions for increasing researcher and research team 
awareness of data warehouses and their use in clinical and translational science.  For example, is 
a presentation regarding basic data warehouse functions and processes adequate to raise 
awareness or is a more significant intervention required?  Without appropriate interventions, a 
generation of research teams may be unaware of the data warehouses available to them, resulting 
in ineffective and inefficient research processes as well as a lack of experience with the 
necessary informatics methods to face future research challenges. 
Second, while CTSA hubs often provide data warehouse training for research teams, little is 
known about the outcomes of this training.  For example, at the end of training, can research 
team members demonstrate accurate knowledge regarding the data warehouses available to 
them?  Can trainees perform activities within the data warehouses that support their intended 
study outcomes?  Without assessment of these activities, CTSA hubs may be investing 
significant time and money into training programs that are not achieving their intended learning 
objectives. 
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Finally, a critical gap exists in defining objective measures for determining if research teams 
perform the necessary data warehouse activities to achieve their intended research outcomes.  
Without this information, the NIH and CTSA hubs are unable to determine if a return on 
investment is occurring for the significant time and resources involved in implementing and 
maintaining data warehouses. 
As a result, critical needs exist to identify interventions that increase research team awareness of 
data warehouses, to assess outcomes of data warehouse training, and to define objective 
measures for determining if research teams perform the necessary data warehouse activities to 
achieve their intended research outcomes.  
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CHAPTER 3: CONCEPTUAL FRAMEWORKS 
To address the critical needs identified in the previous chapter, this study includes a presentation 
intervention to raise researcher awareness of data warehouses, assessments of the awareness 
intervention and existing data warehouse training, and definition and use of objective measures 
for data warehouse activities related to research outcome achievement.  The design of these 
study components is based on four conceptual frameworks related to adoption of technology and 
assessment of learning objectives: Diffusion of Innovation theory, Technology Acceptance 
Model, DeLone and McLean Information Systems Success Model, and Bloom’s Taxonomy of 
Educational Objectives.  Because these frameworks have been applied in a variety of contexts 
and have proven to be reliable and robust, they provide a solid theoretical foundation for this 
study.  This chapter provides a summary of these frameworks, as well as examples of their 
applications in healthcare environments and/or with data warehouse implementation and use. 
3.1 Technology Adoption Models 
One of the key research areas within information systems is understanding how and why 
individuals adopt new information technologies.79  Typically, this research focuses in one of 
three areas:  implementation success at an organizational level, individual acceptance, or task-
technology fit.79  While many theories and models have been proposed based on these areas, 
several have been widely accepted and researched for various industries, contexts, and systems: 
Diffusion of Innovation theory, Technology Acceptance Model, and DeLone and McLean 
Information Systems Success Model.  This section will describe the theoretical basis for each 
these models and provide the key findings in studies that apply them. 
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3.1.1 Diffusion of Innovation (DOI) Theory 
Created by Everett M. Rogers in 1962, the DOI theory is the most widely used theoretical basis 
for studying technology adoption, which is defined as “…a decision to make full use of an 
innovation as the best course of action available.”9,80  According to Rogers, “diffusion is the 
process in which an innovation is communicated through certain channels over time among the 
members of a social system.”9  Based on this definition, DOI has four main elements:  the 
innovation, communication channels, time, and a social system.  An innovation is an idea, 
practice, or object that is perceived to be new by the individual.9  A communication channel is 
the means used to share messages from one individual to another such as mass media and 
interpersonal channels.9  Time is defined in three ways: time from awareness to adoption or 
rejection, time to accept an innovation relative to other individuals within the social system, and 
the rate of innovation adoption.9  Finally, a social system is the interrelated individuals, groups, 
or organizations that engage in joint problem solving to accomplish a common goal.9 
Using this definition as a basis, Rogers identified a five stage innovation-decision process, which 
is “…the process through which an individual…[passes] from gaining initial knowledge of an 
innovation, to forming an attitude toward the innovation, to making a decision to adopt or reject, 
to implementing new ideas, and to confirming this decision.”9  The following table summarizes 
these stages.9 
Table 1. Stages within the Innovation-decision Process 
Stage Description 
Knowledge Individual is made aware of an innovation’s existence and gains 
understanding of how it functions 
Persuasion Individual forms an attitude (favorable or unfavorable) towards the 
innovation 
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Stage Description 
Decision Individual engages in activities that lead to a decision (adoption or 
rejection) 
Implementation Individual puts the innovation into use 
Confirmation Individual seeks reinforcement for his/her decision and may change 
this decision if exposed to conflicting messages about the innovation 
Within the knowledge stage, individuals may either passively receive knowledge (such as being 
exposed to innovation information during a department meeting) or actively seek knowledge 
based on an identified need (such as wanting to gain access to health care data and investigating 
potential data sources).9  This first exposure to innovation is known as awareness-knowledge.9  
Based on this exposure, an individual may seek out how-to knowledge (information about using 
an innovation properly) and principles-knowledge (information about how the innovation 
works).9  While those looking to influence innovation adoption often focus on awareness, they 
may be more effective by also focusing on how-to knowledge delivery.9 
While the knowledge stage is mostly cognitive, the persuasion stage is more about feelings 
toward the innovation, which lead to the formation of attitude.9  Attitude is defined as “…a 
relatively enduring organization of an individual’s beliefs about an object that predisposes his or 
her actions.”9  In forming this attitude, individuals will actively seek out information about the 
innovation, determine the credibility of the messages received about the innovation, and interpret 
the information that is received, all with the goal of reducing the uncertainty that is inherent in 
adopting innovations.9  Often, individuals will also mentally apply the innovation to their current 
or future situations as a way to further reduce their uncertainty.9 
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Based on the attitude developed in the persuasion stage, the individual will decide to adopt or 
reject the innovation.  To cope with uncertainty, some individuals may try out the innovation on 
a small-scale basis, and those who perform this trial will often move toward an adoption 
decision.9  Other individuals may look to a peer to use the innovation before adopting the 
innovation themselves or to demonstrations of the innovation that align with their needs.9 
If an adoption decision is made, the next stage is implementation, where the individual puts the 
innovation to use.  To this point, the process has been a mental exercise, but implementation 
involves true behavior change.9  At this stage, uncertainty exists, particularly in understanding 
where the innovation can be obtained, how it is used, and how problems can be solved, so 
support is needed to help reduce this uncertainty.9 
Finally, as individuals use an innovation, they may decide to continue or discontinue its use 
based on their experiences and/or messages received regarding the innovation during the 
confirmation stage.9  Typically, decisions to discontinue use of an innovation fall into one of two 
categories: replacement or disenchantment.9  Replacement discontinuance occurs when an 
individual rejects an innovation in order to adopt a better innovation (such as upgrading from the 
current iPhone version to a new iPhone version).9  Disenchantment discontinuance occurs when 
an individual rejects an innovation due to dissatisfaction with its performance, which may be 
caused by lack of compatibility between the innovation and individual need or misuse of the 
innovation.9 
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The rate of adoption, measured by the number of individuals who use an innovation in a 
specified period, can vary significantly.9  Although the communication channel and social 
system influence this rate, the majority of this variance can be explained by five attributes of an 
innovation:  relative advantage, compatibility, complexity, trialability, and observability.9  The 
following table summarizes these attributes.9 
Table 2. Attributes of Innovation 
Attribute Description 
Relative advantage The degree to which an innovation is perceived as being better than 
the innovation it supersedes 
Compatibility The degree to which an innovation is consistent with an individual’s 
existing values, past experiences, and needs 
Complexity The degree to which an innovation is perceived as difficult to 
understand and use 
Trialability The degree to which an innovation may be used on a limited trial 
basis 
Observability The degree to which the results of the innovation are visible to 
others 
Within healthcare settings, the DOI theory stages and attributes of innovations have been applied 
in a variety of contexts such as adoption of integrated care pathways (plans of patient care for 
specific diagnoses or interventions), telemedicine, EHRs, and health care delivery models.81,82  In 
the majority of cases, the DOI theory has proven to be a solid theoretical foundation with 
consistent empirical support that can be used to explain an individual’s adoption process, 
especially in the knowledge, persuasion, and decision stages.80  In all contexts, the main criticism 
of this theory is the focus on individual versus organization adoption of innovation.80  
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3.1.2 Technology Acceptance Model (TAM) 
Similar to the concept of adoption, technology acceptance is an individual’s psychological state 
regarding his/her voluntary or intended use of a technology, and studies have found that this 
intention to use a technology can be used to predict actual use of that technology.83–85  The TAM 
is an adaptation of the Theory of Reasoned Action (TRA) specifically for modeling and 
predicting user acceptance of information systems.86  The TRA states that an individual’s 
intention to perform a behavior is based on his/her attitude toward the behavior and his/her 
perception that important individuals to him/her believe the behavior should or should not be 
performed (known as subjective norm).83  Although based on the TRA, the TAM does not 
include the concept of subjective norm and identifies two particular beliefs, perceived usefulness 
and perceived ease of use, that are relevant to acceptance of technology.83  The following table 
summarizes the concepts used within the TAM. 
Table 3. Concepts within the Technology Acceptance Model 
Concept Acronym Definition 
External variables (none) External factors such as human, social, and 
system factors83,87 
Perceived usefulness PU An individual’s perception that using a 
particular technology will enhance his or her 
job performance79,83,86 
Perceived ease of use PEOU An individual’s expectation that using the 
system will be free of effort79,83,86 
Attitude toward using 
technology 
A An individual’s feelings (positive or negative 
about performing a behavior79,83,86 
Behavioral intention BI Measure of the strength of an individual’s 
intention to perform a specified behavior83 
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According to the TAM, these beliefs determine an individual’s attitude toward the technology.  
In addition, attitude and perceived usefulness determine behavioral intention.  Finally, these 
beliefs are influenced by external variables such as available training, organizational support, and 
system features.83,87  These relationships are shown in the following figure. 
Figure 1. Technology Acceptance Model 
 
Adapted from Davis et al., 1989. 
The TAM has been well tested in a variety of business and healthcare contexts and has proven to 
be reliable and robust in predicting technology acceptance.88,89  The following table provides a 
summary of several studies and their results within healthcare contexts. 
Table 4. Results of Using the Technology Acceptance Model in Healthcare Contexts 
Population Technology Prediction of BI 
Physicians Telemedicine 42-44% of observed 
variance in BI85,90 
Physicians Internet-based health 
applications 
59% of observed variance 
in BI88 
Residents and physicians Personal digital assistants 
(PDAs) 
57% of observed variance 
in BI91 
Physicians, nurses, and medical 
technicians in Taiwan 
Mobile health 70% of observed variance 
in BI92 
Medical personnel in Taiwan Adverse event reporting 
system 
59% of observed variance 
in BI93 
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Population Technology Prediction of BI 
Hospital personnel in Greece Hospital information systems 87% of observed variance 
in BI94 
Nurses Remote intensive care unit 
monitoring (eICU) 
58% of observed variance 
in BI95 
Physicians EHRs 44-56% of observed 
variance in BI96,97 
 
Within these studies, the typical approach is to survey or interview a sample population using a 
series of items designed to assess the concepts within the model.  Each concept is assessed using 
multiple items that include a mix of positive and negative statements.  For example, some ease of 
use items are “Learning to operate [technology] is easy for me” and “I believe that it is easy to 
get a [technology] to do what I want it to do.”98,99  Responses to these items are measured using a 
five- or seven-point Likert-type scale with values ranging from strongly agree to strongly 
disagree.92,99  Likert responses are then converted to numeric equivalents, and data analysis is 
typically performed using structured equation modeling (SEM) to determine the effect of each of 
the concepts. 
Based on this analysis, the majority of studies using the TAM have found perceived usefulness to 
be a strong determinant of intention to use.83,85,95–97,99–102,86–89,91–94  In comparison, studies have 
shown mixed results for perceived ease of use, with some studies indicating a strong link 
between PEOU and intention to use83,86,92–97,101,102 and others indicating PEOU is not a 
significant determinant.85,87–89,91,99,100  Generally, perceived ease of use was identified as a 
secondary determinant to perceived usefulness.83  As stated by Davis et. al, “users may be 
willing to tolerate a difficult interface in order to access functionality that is very important, 
while no amount of ease of use will be able to compensate for a system that doesn’t do a useful 
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task.”83  Interestingly, studies involving physicians were more likely to find that PEOU was not a 
significant determinant, which researchers postulate is due to a higher level of competence, 
intellectual and cognitive capacity, adaptability to technology, and operational support for 
physicians in comparison to other populations studied.85,89,90,99 
Several themes emerged from these studies. One common theme was the need for users to 
recognize the technology as compatible with their work tasks and job performance in order to 
perceive the technology as useful.84,92,103  Training was also a recurrent theme, indicating that 
training interventions focusing on the benefits of the technology as well as including content 
regarding real-life scenarios influenced perceived usefulness and attitude.87,91,92,94,96  Also 
identified was the need for appropriate ongoing support for the technology once training was 
complete.87,92,102  Another theme was the need to demonstrate the effectiveness of a technology, 
particularly in comparison to the status quo, to improve attitude and perceived usefulness of a 
technology.84,91  Finally, although intention has been shown to be a good predictor of actual use 
of a technology, researchers identified the need to include objective measures of actual use 
whenever possible.86,104 
3.1.3 DeLone and McLean Information Systems Success Model 
One of the first models used to measure successful implementation of information systems was 
created by DeLone and McLean in 1992.  Known as the DeLone and McLean Information 
Systems (D&M IS) Success Model, the model is an attempt to define a dependent variable for 
information system (IS) research, as the evaluation of practices, policies, and procedures requires 
an established dependent variable.105  The original model identified six interrelated dimensions 
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as categories of IS success.105,106  In 2003, ten years after the initial publication of this model, 
DeLone and McLean updated the model based on the research studies conducted during that time 
period.  At that time, two extensions of the model were identified: the addition of service quality 
and the introduction of net benefits to address all the impacts (including individual and 
organization) of a system.106  The following table summarizes these dimensions and typical 
measurements used. 
Table 5. D&M IS Success Model Dimensions 
Dimension Model Year Description Example Measurements 
System quality105,106 1992 Measure of the system 
characteristics105,107 
Ease of use, functionality, 
reliability, flexibility, data 
quality, portability, 
verifiability, and 
integration106–108 
Information 
quality105,106 
1992 Measure of the 
characteristics of the 
information output provided 
by the system105,107 
Accuracy, timeliness, 
completeness, relevance, 
understandability, and 
consistency106,107 
Use105,106 1992 Measure of the use of the 
information by decision 
makers and intended users 
in a voluntary context105,107 
Frequency of use, self-
reported use, actual use, 
time of use, appropriateness 
of use, number of accesses, 
and usage pattern106–108 
User 
satisfaction105,106 
1992 Measure of the satisfaction 
experienced by decision 
makers and intended users 
in a non-voluntary 
context105,107 
Satisfaction ratings for 
specific systems and scales 
used to assess attitudes and 
satisfaction105,107 
Individual 
impact105,106 
1992 Measure of the effect of the 
information on the behavior 
of the recipient105 
Job performance, decision-
making performance, and 
quality of work 
environment106,108 
Organizational 
impact105,106 
1992 Measure of the effect of the 
information on the 
performance of an 
organization105 
Costs and benefits, 
contribution to company 
profits, and return on 
investment105,108 
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Dimension Model Year Description Example Measurements 
Service quality106 2003 Measure of the service 
provided by IS organizations 
to end users106 
Currency, reliability, 
responsiveness, assurance, 
and empathy106,108 
Net benefits106 
(replaces individual 
and organization 
impact) 
2003 Measure of all impacts (e.g., 
individual, workgroup, 
organizational, and industry) 
and benefits of a 
system106,107 
Improved decision making, 
improved productivity, 
increased sales, cost 
reductions, creation of jobs, 
and economic 
development107 
 
Since its publication, this model has been widely accepted as a framework for IS success 
measurements.107,108  Further research has focused on identifying the independent variables that 
may “cause” this success.  Research by Petter, DeLone, and McLean published in 2013 identifies 
several variables that serve as strong determinants of overall IS success: enjoyment, trust, user 
expectations, extrinsic motivation, and IT infrastructure.107  Several other variables were 
identified as strong determinants for specific IS success dimensions.  The following table 
summarizes these findings.107 
Table 6. Determinants of IS Success Dimensions 
Determinant Overall IS Success 
System 
Quality Use 
User 
Satisfaction 
Individual 
Impact 
Task compatibility    Strong  
Attitudes toward technology    Strong  
Enjoyment Strong     
Self-efficacy  Strong    
Trust Strong     
User expectations Strong   Strong  
Technology experience  Strong    
Management support     Strong 
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Determinant Overall IS Success 
System 
Quality Use 
User 
Satisfaction 
Individual 
Impact 
Extrinsic motivation Strong  Strong   
Organizational competence   Strong   
IT infrastructure Strong  Strong   
Adapted from Petter et al., 2013. 
These determinants are the interrelated, independent variables for the dependent variable of IS 
success.  The following figure summarizes these relationships. 
Figure 2. Determinants and Dimensions of IS Success 
 
Adapted from Petter et al., 2013, and DeLone and McLean, 2003. 
The D&M IS Success Model has been applied to numerous IT systems, including the 
implementation and use of data warehouses.109  Applying this model to data warehouse projects 
is particularly important, as studies have reported project failure rates from 41-90%.110–112 
Typically, studies applying the D&M IS Success Model survey or interview a sample group with 
the goal of identifying factors that determine successful system implementation and use.109 Each 
potential factor is measured using multiple items with responses recorded using a seven-point 
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Likert-type scale with values ranging from strongly agree to strongly disagree.109,113  For 
example, items measuring data quality include “Users have more accurate data now from the 
data warehouse than they had from source systems” and “I can get data that is current enough to 
meet my work needs.”109,113  Likert values are then converted to numeric values and analyzed 
using a variety of statistical techniques, such as partial least squares, regression, and hypothesis 
testing.7,109,110,113 
Based on this analysis, several factors have emerged as critical to the successful implementation 
and use of data warehouses.  First, the quality of the data warehouse (system quality) and the 
data (information quality) have been found to be key factors associated with net benefits of using 
the system.108–110  Also influencing net benefits is the degree to which the features and functions 
provided by the data warehouse align with business needs and user tasks.110,114  Management 
support, training, and appropriate resources to implement and support the data warehouse have 
been found to improve user satisfaction.7,108,109,114–118 
3.2 Bloom’s Taxonomy of Educational Objectives 
Because training was identified as an influencing factor within the TAM and D&M IS Success 
Model, an understanding of educational objectives also provides a framework for this study.  
Bloom’s Taxonomy of Educational Objectives (known as Bloom’s Taxonomy) is a framework 
for classifying what students are meant to learn as a result of instruction.119  The goal of this 
taxonomy is to help educators in two ways: to clarify their intended outcomes and to inform the 
design of appropriate instruction and assessment methods.120  Originally envisioned as a method 
for facilitating the exchange of test items among faculty at various higher education institutions, 
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this taxonomy has become widely known, resulting in its translation into 22 languages and use in 
all levels of education.119   
The original taxonomy, published in 1956, provided six distinct levels of learning: knowledge, 
comprehension, application, analysis, synthesis, and evaluation.119  These levels are organized in 
a cumulative hierarchy, where the ordering is simple to complex and from concrete to abstract, 
so that each simpler level must be mastered before the next more complex level.119  In 2001, a 
revision of the original taxonomy was published, which provided changes to the naming of each 
level to reflect more modern language.119–121  The following table describes each revised 
level.119,121  
Table 7. Cognitive Levels within the Revised Bloom’s Taxonomy 
Level Description 
Remember Able to retrieve relevant information from long-term memory 
Understand Determine the meaning of instructional messages (oral, written, and 
graphic) 
Apply Carry out or use a procedure in a given situation 
Analyze Break material into parts and detect how the parts relate to one another 
and the overall concept 
Evaluate Make judgments based on criteria and standards 
Create Put elements together to create a novel, coherent whole or an original 
product 
This revision also identified four types of knowledge that could be assessed using the cognitive 
levels.119,120  Three of these types were included in the original taxonomy (factual, conceptual, 
and procedural) and a fourth (metacognitive) was added in the revision.119  The following table 
describes each of these types and typical knowledge covered by each type. 
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Table 8. Knowledge Types within the Revised Bloom’s Taxonomy 
Type Description Typical Knowledge 
Factual Basic elements that a student 
must know to be acquainted with 
and solve problems within a 
specific discipline119,120 
 Terminology 
 Specific details and elements119 
Conceptual Interrelationships among the 
basic elements that allow them 
to function together119,120 
 Classifications and categories 
 Principles and generalizations 
 Theories, models, and structures119 
Procedural  How to do something 
 The methods of inquiry 
 The criteria for using skills, 
algorithms, techniques, and 
methods119,120 
 Subject-specific skills and 
algorithms 
 Subject-specific techniques and 
methods 
 Criteria for determining when to use 
appropriate procedures119 
Metacognitive  Knowledge of cognition, in 
general 
 Awareness and knowledge of 
one’s own cognition119,120 
 Strategic knowledge 
 Cognitive tasks, including 
appropriate contextual and 
conditional knowledge 
 Self-knowledge119 
The combination of knowledge type and cognition level provides a two-dimensional 
representation of learning objectives.  For example, a learning objective that states, “identify the 
four types of knowledge represented in Bloom’s taxonomy” would be factual knowledge at the 
remember cognitive level.  In contrast, a learning objective that states, “Design program-level 
learning outcomes based on Bloom’s taxonomy” would be conceptual knowledge at the create 
cognitive level.   
Based on these dimensions, assessments are created to determine if the learning objectives have 
been met.  For the first example objective above, a simple multiple-choice test item may be 
sufficient to confirm that this objective has been met.  In the second example, a summative report 
outlining the research performed to define and determine the outcomes, as well as the outcomes 
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themselves, may be an appropriate assessment.  These assessments should be linked to the 
objectives as well as the content of the instruction provided.120 
3.3 Application of Conceptual Frameworks in this Study 
This study included a presentation intervention to raise awareness of data warehouses among 
research teams, assessments of the awareness intervention and existing data warehouse training, 
and definition and use of objective measures for data warehouse activities related to research 
outcome achievement.  This section summarizes the use of the conceptual frameworks in 
designing each of these components. 
The study approach mirrored the five innovation-decision stages identified in the DOI theory.  In 
the knowledge stage, Rogers recommends providing awareness-knowledge and how-to 
knowledge to influence innovation and adoption.  As a result, this study included an intervention 
to provide awareness-knowledge and use of an existing training process to provide how-to 
knowledge.   
In the persuasion stage, individuals actively seek out information regarding the innovation and 
mentally apply an innovation to their current or future states.  As a result, this study included a 
process for individuals to request access and training for a data warehouse.  In addition, the 
request involved in this process required the individual to identify potential applications of the 
data warehouse in his/her research project. 
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In the decision stage, individuals who try out an innovation are more likely to adopt that 
innovation.  As a result, part of the training provided within this study included hands-on 
experience using a data warehouse. 
In the implementation stage, individuals need support to put an innovation to use.  As a result, 
this study included distribution of support information (e.g., how to obtain access to the data 
warehouse and who to contact with questions) during the awareness intervention and training. 
In the confirmation stage, individuals decide to continue or discontinue using the innovation.  
Deciding to discontinue can be due to a replacement innovation or disenchantment with the 
innovation.  As a result, the awareness intervention and training included information about the 
benefits of using a data warehouse instead of paper chart review or EHR chart review for 
common research tasks to influence replacement of the existing methods.  In addition, the 
awareness intervention and training provided realistic expectations about how the data 
warehouse can be used for research purposes.  Appropriate expectations were critical to avoid 
disenchantment with data warehouses. 
Based on the TAM and D&M IS Success Model, the awareness intervention and training 
included the following: 
 Realistic expectations for system and information quality. 
 Information about the usefulness of a data warehouse for common research tasks (task 
compatibility). 
 Description of the benefits that can be achieved using a data warehouse (net benefits). 
 Information for obtaining data warehouse support. 
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Using Bloom’s Taxonomy, the learning objectives for the awareness intervention and training 
were written.  This study included assessment of these learning objectives based on the 
knowledge type and cognitive level. 
This study also included a follow-up assessment 30 days after completion of training to assess 
factors identified as significant by the TAM and D&M IS Success Model, including ease of use 
for data warehouse tools, availability of support, and benefits and barriers to using a data 
warehouse. 
Finally, the TAM identifies the need to objectively measure the adoption and use of technology. 
As a result, this study included measures of the number of requests for data warehouse access, 
the number of requests for data warehouse training, and the number of individuals completing 
the associated data warehouse activities to achieve their intended research outcomes. 
The following table provides a summary of the conceptual frameworks and their application 
within this study. 
Table 9. Summary of Conceptual Frameworks 
Framework Application to Study 
Diffusion of Innovation 
(DOI) theory 
 Provides the stages of innovation adoption, which were used as 
the basis for the study approach. 
 Identifies the activities that indicate movement between the 
stages of technology adoption, which were used assess the 
progression of individuals from one stage to the next within the 
study. 
 Describes reasons for discontinuing the use of an innovation, 
which were used to inform potential barriers included in the 
post-training assessment within this study. 
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Framework Application to Study 
Technology Acceptance 
Model (TAM) and 
DeLone & McLean IS 
Success Model 
 Describes key content influencing technology adoption 
highlighted within the awareness presentation intervention and 
the existing training. 
 Identifies key aspects influencing technology 
adoption/acceptance, which provided the focus for the 
assessments within this study. 
 Identifies that assessment of factors influencing technology 
adoption should be combined with objective measurement of 
system use, which provided the reason for including the 
objective measurement component of this study. 
Bloom’s Taxonomy of 
Educational Objectives 
 Describes a framework for creation of learning objectives, 
which was used to create objectives for the awareness 
presentation intervention and existing training. 
 Provides levels of assessment based on objectives, which was 
used to determine the appropriate assessment for each learning 
objective identified for the awareness presentation intervention 
and existing training. 
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CHAPTER 4: METHODS 
Within this chapter, the research design and approach for this study are described.  Details are 
provided regarding the organization and target population involved; the research hypotheses, 
procedures, and assessment tools for each of the study components; project information 
describing the researcher’s role and the project’s timeline and budget; and the limitations of this 
research study. 
4.1 Research Design 
This research study applied a mixed methods approach to evaluate a presentation intervention to 
raise awareness of data warehouses, to assess existing data warehouse training, and to define and 
use objective measures for data warehouse activities related to research outcome achievement.  
While the majority of the data collected within this study were quantitative in nature, some 
qualitative information was gathered to better understand the reasoning underlying the 
quantitative responses. 
4.2 Organizational Background 
This research study was conducted with the Clinical and Translational Science Institute (CTSI) 
of Southeast Wisconsin.  Founded in 2010, the CTSI is a consortium of eight regional 
organizations including the BloodCenter of Wisconsin (BCW), Children’s Hospital of Wisconsin 
(CHW), Clement Zablocki VA Medical Center (VA), Froedtert Hospital, Marquette University 
(MU), Medical College of Wisconsin (MCW), Milwaukee School of Engineering (MSOE), and 
University of Wisconsin-Milwaukee (UWM).122  Awarded a $20 million CTSA in 2015, the 
CTSI has a mission of advancing the health of the community through research and discovery.122  
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Currently, the research portfolio includes more than 185 studies, including 47 collaborative 
research studies.122  Within the CTSI, the BMI department provides consultative services, 
solutions for data management (such as REDCap, Confluence, and OnCore), and access to 
clinical data through the image de-identification service and the Clinical Research Data 
Warehouse (CRDW).123  The CRDW and its use was the focus of this research study. 
4.2.1 Overview of the CRDW 
The CRDW is a data warehouse that contains data from a variety of sources including the 
Froedtert & Medical College of Wisconsin EHR (Epic), CHW EHR (Epic), MCW physician 
billing system (GE/IDX), Froedtert Hospital legacy systems (Affinity, Intellidose, and SIS), and 
the MCW tissue bank.124  This data includes, but is not limited to, patient demographics, 
diagnoses, clinical encounters, lab results, medications, procedures, specimen information, 
enrollment in clinical trials, and information from clinical registries.  Currently, the CRDW 
includes more than 1.9 million patient records, 524 million patient encounters, and 2.9 billion 
clinical facts.124 
To access this data, the BMI department provides three self-service tools for querying the 
CRDW and extracting data: 
 Informatics for Integrating Biology & the Bedside (i2b2) can be used to query the CRDW for 
developing hypotheses, determining feasibility, obtaining cohort counts for grant 
submissions, and defining cohorts for data analysis.  All data queried through this tool is de-
identified and is organized in a concept tree structure. 
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 TriNetX is an additional query tool that is sponsored by the pharmaceutical industry.124  
Similar to i2b2, TriNetX can be used for developing hypotheses, determining feasibility, 
obtaining cohort counts for grant submissions, and defining cohorts for data analysis.  All 
data queried through this tool is de-identified and is organized by demographics, diagnoses, 
procedures, medications, lab results, and cohort analysis. 
 Honest Broker is a data extraction tool that can use manual input or queries from i2b2 or 
TriNetX to extract data for an identified set of patients.  The extractions may contain de-
identified or identified data.  While Honest Broker contains standard data tables that can be 
used for extraction, individuals also have the option to have custom tables created based on 
the needs of their studies. 
4.2.2 Current CRDW Processes 
Currently, the BMI department does not have a repeatable, standardized process for raising 
awareness of the CRDW and related tools.  Individuals learn about the CRDW in a myriad of 
ways, such as through information on the CTSI website, conversations with other research team 
members, and contact with the BMI department.  Upon request, BMI representatives have 
presented CRDW information at meetings for departments and/or research teams. 
To obtain access to the CRDW tools, an individual joins the CTSI and confirms that he/she has 
current Collaborative Institutional Training Initiative (CITI) training for Human Subjects 
Research.  Once these items are complete and a potential research project has been identified, the 
individual completes a feasibility or data release agreement identifying the principal investigator, 
a description of the research, and other relevant information such as the intended outcome of the 
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project (e.g., grant submission and abstract).  Currently, access to these tools requires that the 
principal investigator be a member of the MCW faculty or have an adjunct faculty appointment 
with MCW.  In addition, individuals must have an MCW domain account. 
Once the agreement is completed and access is granted, the individual may begin using 
independently i2b2, TriNetX, and Honest Broker.  In addition, the BMI Business Analyst 
contacts the individual to offer one-on-one or small group training.  The purpose of this 
voluntary training is to review the data contained within the CRDW; discuss the proposed project 
and potential to complete the project within the CRDW; and demonstrate use of the query and 
extraction tools based on the project needs.  Individuals are also provided contact information for 
the BMI Business Analyst and encouraged to contact the analyst for assistance as needed.  All 
activity within the CRDW tools is tracked and documented using audit trails.  These audit trails 
have been in use since the inception of the CRDW tools. 
On an annual basis, the CTSI BMI department provides information to NCATS regarding 
achievement of program goals.  Currently, this information includes number of individuals 
granted access, number of training sessions completed, and general information about outcomes 
achieved (such as the number of grant submissions completed).  To provide this information, the 
CTSI BMI department tracks all CRDW access and training requests in a system called RISE.  
These requests have been tracked in RISE since 2016. 
4.3 Study Overview 
This research study was divided into four components.  The following section provides a brief 
introduction to these components, a listing of the research questions and hypotheses related to 
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each component, a description of the target population for this study, a description of the roles 
and responsibilities within the study team, and an overview of the data processing and analysis 
performed. 
4.3.1 Overview of Study Components 
In the first component of this study, the awareness presentation intervention, a representative 
from the BMI department delivered 20-minute presentations to members of the CTSI research 
community.  The purpose of these presentations was to raise awareness of the CRDW and its 
potential benefits with the goal of influencing the participants to move to the next stage in the 
DOI process (from knowledge to persuasion).  To assess the knowledge obtained, participants 
completed pre- and post-assessments that measured their knowledge of the CRDW, as well as 
their self-reported likelihood to use the CRDW.  To encourage participants to answer honestly 
and without fear of judgment, no identifying information (e.g., name, role/position, or 
department) was captured during the assessments.  Increased accuracy of knowledge from pre- to 
post-assessment, as well as an increase in the self-reported likelihood to use would indicate 
progress in the DOI process to adopt the CRDW. 
In the second component, the existing CRDW training process was assessed.  Trainees 
completed pre- and post-assessments during the training session to assess the knowledge 
obtained and self-reported likelihood to use.  In addition, trainees identified the potential 
outcomes for which the CRDW could be used (e.g., poster presentation, grant submission, and 
manuscript).  To encourage trainees to answer honestly and without fear of judgment, no 
identifying information (e.g., name, role/position, or department) was captured during the 
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assessments.  To assess progress from the knowledge stage of the DOI theory to the persuasion 
stage, the study used an increase in the accuracy of knowledge as well as an increase in self-
reported likelihood to use as measurements.  Additionally, the study captured the number of 
potential outcomes of CRDW use identified by trainees.  An increase in the number of potential 
outcomes identified was hypothesized to indicate progress in the DOI process to adopt the 
CRDW. 
In the third component, data from several BMI information systems was used to objectively 
measure outcomes achieved from the first two components.  First, based on the DOI theory, if 
the awareness intervention was sufficient, the number of individuals requesting CRDW access 
and training should increase as they move from obtaining awareness-knowledge to seeking out 
more information about the CRDW as part of the persuasion stage.  Within this study, data from 
the request tracking system RISE were used to obtain objective measures of these counts.  In 
addition, if the training provided sufficient information, the majority of trainees should perform 
the necessary CRDW activities within 30 days of training to achieve their intended research 
outcomes.  Currently, no objective measure exists for these activities; as a result, majority was 
defined as “at least 50%.”  Data from the feasibility agreement, data release agreement, and 
CRDW tool audit trails were used to track trainee activity within the CRDW to objectively 
measure trainee completion of the activities related to their intended research outcomes.   
During the fourth and final component, trainees participated in a 30-day post-training 
assessment.  The purpose of this assessment was to explore what factors may have influenced 
their decisions to adopt or reject use of the CRDW, as well as their completion of CRDW 
activities related to their intended research outcomes.  Because these assessments were linked to 
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specific trainees, the study researcher provided an informational letter to each trainee indicating 
the confidentiality of the results so as to encourage honest responses to assessment items. 
4.3.2 Research Questions and Hypotheses 
These four components answer the following research questions by testing the following 
hypotheses: 
Q1: Is delivering a 20-minute presentation regarding CRDW basic functions and processes a 
sufficient intervention to raise awareness of the CRDW for clinical and translational 
research purposes? 
H1:  Awareness presentations will increase the average number of correct answers 
from the pre-assessment to the post-assessment. 
H2:  Awareness presentations will increase the average self-reported level of 
likelihood to use from the pre-assessment to the post-assessment. 
H3:  The growth rate of CRDW access requests for individuals and projects will 
increase during the awareness presentation intervention period in comparison to 
the growth rate from 2016-2017 for the same time period. 
H4:  The growth rate of CRDW training requests for research project teams will 
increase during the awareness presentation intervention period in comparison to 
the growth rate from 2016-2017 for the same time period. 
Q2: Does existing CRDW training provide sufficient information for trainees to perform the 
CRDW activities related to their intended research outcomes? 
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H5:  CRDW training will increase the average number of correct answers from the pre-
assessment to the post-assessment. 
H6:  CRDW training will increase the average number of identified potential outcomes 
from the pre-assessment to the post-assessment. 
H7:  CRDW training will increase the average self-reported level of likelihood to use 
from the pre-assessment to the post-assessment. 
H8:  Within 30 days of receiving CRDW training, at least 50% of individuals will 
complete the CRDW activities required to achieve their intended research 
outcomes. 
Q3: What potential factors influence trainees’ use of the CRDW for clinical and translational 
research purposes? 
4.3.3 Target Population 
The target population for this study was members of the CTSI research community.  For the 
purposes of this study, “research community” was defined as anyone who conducts research 
and/or participates as a research team member.  This definition included, but was not limited to, 
principal investigators, research coordinators, fellows, medical residents, research administrators, 
and graduate students.  The “CTSI” qualifier referred to anyone who was employed by one of the 
eight organizations participating in the CTSI.  For example, a research fellow employed by BCW 
would be within the target population, while a research fellow employed by the Aurora Health 
Care system would be excluded from the target population.  In addition, all participants must 
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read, speak, write, and comprehend the English language, as that is the language used within all 
the CRDW tools and data.   
4.3.4 Study Roles and Responsibilities 
The principal investigator for this study was Katie McCarthy (identified as “study researcher” 
throughout the remainder of this document).  The study researcher was responsible for: 
 Developing the study design and protocol. 
 Developing the recruitment protocols. 
 Creating the assessment tools for the CRDW awareness presentation intervention, CRDW 
training, and 30-day post-training follow-up. 
 Writing the protocol submission and obtaining approval from the Institutional Review Board 
(IRB). 
  Performing data collection and analysis. 
 Entering and maintaining the study documentation and results. 
 Leading and managing all aspects of the study. 
The study team also included two representatives from the BMI department, who served as 
subject matter experts and participated in the execution of the study protocol.  Kristen Osinski is 
the BMI Business Analyst and served as the primary BMI support for the study researcher.  With 
direction from the study researcher, the BMI Business Analyst was responsible for developing 
and delivering the CRDW awareness presentations and CRDW training sessions.  She also 
executed the recruitment protocols for the CRDW awareness presentations and 30-day 
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post-training follow-up assessments and assisted with data collection.  Finally, she participated in 
review of all the assessments created by the study researcher. 
Bradley (Brad) Taylor is the Chief Research Informatics Officer within the BMI department.  He 
served as the MCW and CTSI sponsor for this study.  In this role, he approved the participation 
of the BMI Business Analyst and ensured the study researcher had access to the BMI tools 
necessary to complete the study.  In addition, he assisted with recruitment for the CRDW 
awareness presentations and delivered some of the CRDW awareness presentations. 
4.3.5 Data Processing and Analysis 
The study researcher performed data preparation, cleaning, and analysis using Microsoft Excel 
2016, R version 3.5.1, and RStudio version 1.1.463.  For all statistical tests, a level of 
significance of 0.05 was used. 
4.4 Study Component #1:  Awareness Intervention 
During this component, a member of the BMI department (the BMI Business Analyst or Chief 
Research Informatics Officer) delivered a 20-minute presentation to a group of individuals from 
the target population.  During the presentation, participants completed pre- and post-assessments 
to determine the knowledge obtained from the presentation content. 
Should this presentation intervention prove sufficient for raising awareness of the CRDW, the 
BMI department plans on implementing this intervention as a standard process.  Based on this 
plan, the minimum sample size for this component mirrored the 3-4 presentations per month that 
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could be sustained by the BMI department as a standard process.  Because the study period was 
three months, the goal was completion of 9-12 presentations during the study period.   
During refinement of the procedure and assessment tools for this component, an average of 
seven individuals participated in each presentation, and 82% of these individuals participated in 
the assessments.  Using this information as a basis for determining minimum sample size, if 
group sizes are 6-8 individuals and 75% participate in the assessment, the potential number of 
completed assessments is 40-72 assessments.  As a result, the minimum sample size for this 
component is 40 completed pre-assessments and associated post-assessments. 
Based on the recruitment protocol developed by the study researcher, a BMI department 
representative (Business Analyst or Chief Research Informatics Officer) contacted leaders 
identified as primary contacts for each CTSI partner organization to determine interest in 
scheduling awareness presentations for groups within their organizations.  When interest was 
expressed by a leader, the BMI representative worked with that leader to schedule an appropriate 
date, time, and location and obtained an estimate of the number of potential attendees.  As part of 
the recruitment protocol, the BMI representative also obtained verbal permission to conduct pre- 
and post-assessments during the scheduled session.  If permission was obtained, the BMI 
representative contacted the study researcher regarding the date and time of the session, location 
of the session, and number of potential attendees. The study researcher used this information to 
prepare the appropriate number of pre- and post-assessment copies for the session. 
62 
4.4.1 Research Procedure 
At the start of the scheduled session, the study researcher explained the purpose of this study and 
pre- and post-assessments, as well as the voluntary nature of the study and the anonymity of the 
results.  To individuals who consented to participate, the study researcher then provided the 
pre-assessment and an envelope to in which to store the completed pre-assessment.  Once the 
pre-assessments were complete, the BMI representative delivered the presentation and answered 
any questions that were posed.  At the end of the session, the study researcher provided each 
individual who completed the pre-assessment with a copy of the post-assessment and instructed 
the individual to store this post-assessment in the same envelope as the pre-assessment.  Once the 
assessments were completed, the study researcher collected all the envelopes.  Finally, the 
number of individuals attending the session and the number of pre- and post-assessment pairs 
completed were documented. 
Only presentations that covered the standard CRDW awareness presentation and conformed to 
this protocol were included within this study component.  For example, if a department requested 
a CRDW presentation that only described one of the CRDW tools, then this presentation was not 
the standard CRDW awareness presentation and was not counted as a presentation for the 
purpose of this study component.  
4.4.2 Content Development 
Based on factors identified by the TAM and D&M IS Success Model as important for 
technology adoption, the study researcher identified learning objectives for the CRDW 
awareness presentation intervention.  Specifically, perceived usefulness and task compatibility 
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were identified as strong determinants; therefore, the presentation objectives focused on key 
elements related to research work that are supported by the CRDW.  These objectives are listed 
below. 
At the completion of this presentation, attendees should be able to: 
 Identify the standard data elements available within the CRDW. 
 Identify the situations where use of CRDW data requires Institutional Review Board (IRB) 
approval. 
 Identify the BMI services that are provided free-of-charge related to the CRDW. 
Based on these objectives and direction from the study researcher, the BMI Business Analyst 
developed the content of the awareness presentation.  In addition, similar presentations have 
been delivered previously by the BMI department, so experience gained from these presentations 
was used to inform the structure and flow of this new presentation.   
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Below is an example of one of the content slides developed for the presentation. 
Figure 3. Example Slide from Awareness Presentation Intervention 
  
4.4.3 Assessment Tool Development 
Using Bloom’s taxonomy, the study researcher classified the presentation objectives as factual 
and conceptual knowledge at the remember cognitive level.  Using these dimensions as a guide, 
the study researcher created an assessment tool with a question related to each objective.  The 
goal of these questions was to determine if the learning objectives for the presentation were 
achieved.  A final question was developed to determine the individual’s self-reported likelihood 
to use the CRDW, with a follow-up question if “unlikely” or “very unlikely” was selected to 
determine the reason for this selection.  The goal of this question was to obtain an indication of 
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the individual’s attitude toward the CRDW (a key component of DOI theory and the TAM 
model) and to gain some qualitative information for anyone indicating a low likelihood of use.   
4.4.4 Refinement of Procedure and Assessment Tool 
To refine the awareness presentation content, assessment, and procedure, the study researcher 
and BMI Business Analyst delivered two presentations to different departments within the MCW 
research community.  A total of 17 individuals participated in these presentations, with 
14 individuals completing the assessments (82%).  Three individuals did not participate as they 
arrived after the pre-assessments were completed.  While the research procedure outlined above 
was followed, the data captured on the assessments was not retained (as the sole purpose of these 
sessions was to refine the content, tools, and procedure).   
During this process, the study researcher identified the following improvements: 
 The original presentation contained too much content to be covered in 20 minutes.  The study 
researcher and BMI Business Analyst modified the content to meet the identified time 
constraints.  A copy of the final presentation is provided in Appendix B: Awareness 
Presentation Content. 
 Because the pre- and post-assessments contain the exact same questions, the study researcher 
copied pre-assessments on one color paper, while the post-assessments were copied on a 
different color.  This process proved helpful in distinguishing between the two assessments 
when they were completed and placed within the same envelope.  This process was 
continued during the research study. 
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 The study researcher reworded the three questions related to the presentation learning 
objectives to reduce ambiguity and better align with the presentation. 
 For the question relating to likelihood to use the CRDW, several individuals completed the 
follow-up question even though they indicated a positive likelihood to use the CRDW.  The 
study researcher changed the formatting of the likelihood question and follow-up question to 
more clearly indicate when the follow-up question should be completed. 
In addition to these sessions, the study researcher had the assessment tool reviewed by an 
individual with expertise in survey design.  This review resulted in some minor wording changes, 
but no substantial content changes.  A copy of the revised assessment is provided in Appendix C: 
Awareness Presentation Assessment Tool. 
4.4.5 Data Processing and Analysis Procedure 
The purpose of study component #1 was to test the following hypotheses: 
H1:  Awareness presentations will increase the average number of correct answers from the 
pre-assessment to the post-assessment. 
H2:  Awareness presentations will increase the average self-reported level of likelihood to use 
from the pre-assessment to the post-assessment. 
To test hypothesis H1, the answers from the first three questions on the awareness presentation 
assessments were analyzed.  The first three questions are shown below. 
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Figure 4. First Three Questions from Awareness Presentation Assessment 
 
Because question #1 had six possible answers, question #2 had one possible answer, and 
question #3 had four possible answers, the maximum number of potential correct answers for 
one assessment was eleven.  Each assessment was reviewed to determine the number of correct 
answers.  For example, if an individual correctly identified five answers for question #1, zero 
answers for question #2, and three answers for question #3, the individual’s correct answer score 
was 8 (5 + 0 + 3).   
The mean and standard deviation for the total number of correct answers were calculated for the 
pre- and post-assessments.  Bar charts and boxplots were used to visualize the results from these 
questions as well as the overall number of correct answers from this section of the assessment.  
Then, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, the study researcher performed 
the appropriate parametric or non-parametric hypothesis testing method.   
68 
To test hypothesis H2, the answers from the fourth question on the awareness presentation 
assessments were analyzed.  The fourth question is shown below. 
Figure 5. Fourth Question from Awareness Presentation Assessment 
 
To process this data, each level of likelihood was assigned a numeric equivalent (“Very Likely” 
was 4, “Likely” was 3, “Unsure” was 2, “Unlikely” was 1, and “Very Unlikely” was 0).  The 
mean and standard deviation for the level of likelihood were calculated for the pre- and post-
assessments.  Bar charts and boxplots were used to visualize the results from this question.  
Because this assessment data uses an ordinal scale of measurement, hypothesis testing was 
performed using a non-parametric method (Wilcoxon matched-pairs signed-ranks test).   
4.5 Study Component #2:  Assessment of CRDW Training 
This study component assessed the existing CRDW training process to determine if sufficient 
information was provided for trainees to complete the CRDW activities related to their intended 
research outcomes.  During this component, the BMI Business Analyst delivered one hour of 
CRDW training to one or more members of a research team.  Because research teams often 
contain individuals with unique skills and work is delegated based on these skills, trainees were 
not required to have attended an awareness presentation prior to training.  For example, a 
principal investigator may have attended an awareness presentation, identified the potential uses 
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for the CRDW in his/her research, and then selected one or more research team members to 
receive CRDW training who had not attended the awareness presentation. 
Because individuals receiving CRDW training may not have participated in the awareness 
presentations, the CRDW training provided the same foundational knowledge covered in the 
awareness presentation, but added hands-on practice using the CRDW for a research project 
identified by the individuals receiving the training.  During the training, pre- and 
post-assessments were completed to determine if sufficient information was provided. 
Because one of the hypotheses to be tested within this study was whether or not the number of 
requests for CRDW training increases, the awareness presentation was the only recruitment used 
for this component.  Due to the anonymity of the participants in the awareness presentations, this 
study component did not link those attending awareness presentations to those attending training 
sessions.  Based on experience gained during the refinement of the procedure and assessment 
tool for this intervention, the goal was to have 75% of trainees complete a pre-assessment and 
associated post-assessment. 
4.5.1 Research Procedure 
This intervention began when one or more members of a research team entered a CRDW 
feasibility or data release agreement.  Upon receipt of this agreement, the BMI Business Analyst 
followed the current CRDW training process and contacted the requestor to determine if the 
requestor (and associated research team members) wanted to schedule CRDW training.   
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If interest was expressed, the BMI Analyst completed the following tasks within the current 
CRDW training process: 
 Worked with the requestor to schedule an appropriate date, time, and location and obtained 
the names of the individuals that would be attending the training.   
 Used the list of names to ensure each trainee had access to the CRDW. 
 Used the information from the agreement to determine the feasibility of completing the 
indicated research project with the CRDW and prepared for the training demonstration.   
During the scheduled session, the BMI Analyst followed the study protocol and explained the 
purpose of this research study and the pre- and post-assessments, as well as indicated that 
participation in the study was voluntary and the results were anonymous.  Trainees who 
consented to participate were provided the pre-assessment and an envelope in which to store the 
completed pre-assessment.  Once the pre-assessments were complete, the BMI Business Analyst 
provided the training, allowed the trainees to try hands-on activities within the CRDW, and 
answered any questions that were posed.  At the end of the session, each trainee who completed 
the pre-assessment was provided a copy of the post-assessment and asked to store this 
post-assessment in the same envelope as the pre-assessment.  Once complete, all the envelopes 
were collected by BMI Business Analyst and then provided to the study researcher. 
Only training sessions that covered the standard CRDW training content and conformed to this 
protocol were included within this study component.  For example, if a researcher requested 
refresher training focusing on a specific area of confusion, then this training session did not 
cover the standard CRDW training content and was not counted as a training session for the 
purpose of this study component. 
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4.5.2 Content Development 
The BMI Business Analyst developed the existing CRDW training and has used this training 
approach and content for approximately two years.  As a result, no new content was developed.  
The study researcher reviewed the existing content to ensure it provided the same CRDW 
foundational knowledge as the awareness presentation.  Based on this review, no revisions were 
identified.  Because the hands-on activities are based on the trainee’s potential research project, 
no standard content was available for this portion of the training.   
4.5.3 Assessment Tool Development 
Trainees participating in this component may or may not have attended a CRDW awareness 
presentation.  For example, a research team manager may have attended an awareness 
presentation and encouraged his/her research staff (who did not attend the presentation) to obtain 
CRDW training.  For this reason, the CRDW training provided the same foundational knowledge 
as the awareness presentation to ensure that all trainees obtained the same base knowledge. 
Because the CRDW training covered the same foundational knowledge as the awareness 
presentation, the same three learning objective questions from the presentation assessment were 
included on the training assessment tool.  The goal of these questions was to determine if the 
learning objectives for the training were achieved.   
Because DOI theory indicates that individuals in the persuasion stage of technology adoption 
will mentally consider ways to apply the technology to their current and future needs, the study 
researcher developed a new question to identify the trainee’s intended outcomes in using of the 
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CRDW.  Currently, the feasibility and data release agreement forms for the CRDW include a 
question that asks the individual to indicate his/her intended outcomes in using the CRDW.  The 
options that the individual may select are protocol, poster presentation, grant submission, 
abstract, manuscript, and other.  As a result, these same intended outcome options were used for 
the new assessment question developed by the study researcher.  The goal of this question was to 
identify a trainee’s intended use of the CRDW before and after training.   
Finally, the same question from the awareness presentation assessment related to an individual’s 
self-reported likelihood to use the CRDW was included.  The goal of this question was to obtain 
an indication of the individual’s attitude toward the CRDW (a key component of DOI theory and 
the TAM model) and gain some qualitative information for anyone indicating a low likelihood of 
use.   
4.5.4 Refinement of Procedure and Assessment Tool 
To refine the training assessment and procedure, the BMI Business Analyst delivered two 
training sessions to different research project teams within the MCW research community and 
provided the results to the study researcher.  A total of four individuals participated in these 
presentations, with four individuals completing the assessments (100%).  While the research 
procedure outlined above was followed, the data captured on the assessments was not retained 
(as the sole purpose of these sessions was to refine the tool and procedure).   
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During this process, the study researcher identified the following improvements: 
 Because the pre- and post-assessments contain the exact same questions, the study researcher 
copied pre-assessments on one color paper, while the post-assessments were copied on a 
different color.  This process proved helpful in distinguishing between the two assessments 
when they were completed and placed within the same envelope.  This process was 
continued during the research study. 
 The study researcher reworded the three questions related to the training learning objectives 
to reduce ambiguity and better align with the training.  The changes made were aligned with 
the changes identified during the awareness presentation refinement process. 
 For the question relating to likelihood to use the CRDW, several individuals completed the 
follow-up question even though they indicated a positive likelihood to use the CRDW.  The 
study researcher changed the formatting of the likelihood question and follow-up question to 
more clearly indicate when the follow-up question should be completed.  The changes made 
were aligned with the changes identified during the awareness presentation refinement 
process. 
In addition to these sessions, the study researcher had the assessment tool reviewed by an 
individual with expertise in survey design.  This review resulted in some minor wording changes, 
but no substantial content changes.  A copy of the revised assessment is provided in Appendix D: 
CRDW Training Assessment Tool. 
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4.5.5 Data Processing and Analysis Procedure 
The purpose of study component #2 was to test the following hypotheses: 
H5:  CRDW training will increase the average number of correct answers from the pre-
assessment to the post-assessment. 
H6:  CRDW training will increase the average number of identified potential outcomes from the 
pre-assessment to the post-assessment. 
H7:  CRDW training will increase the average self-reported level of likelihood to use from the 
pre-assessment to the post-assessment. 
To test hypothesis H5, the answers from the first three questions on the training assessments 
were analyzed.  The first three questions are shown below. 
Figure 6. First Three Questions from CRDW Training Assessment 
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Because question #1 had six possible answers, question #2 had one possible answer, and 
question #3 had four possible answers, the maximum number of potential correct answers for 
one assessment was eleven.  Each assessment was reviewed to determine the number of correct 
answers.  For example, if an individual correctly identified five answers for question #1, zero 
answers for question #2, and three answers for question #3, the individual’s correct answer score 
was 8 (5 + 0 + 3).   
The mean and standard deviation for the total number of correct answers were calculated for the 
pre- and post-assessments.  Bar charts and boxplots were used to visualize the results from these 
questions as well as the overall number of correct answers from this section of the assessment.  
Then, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, the study researcher performed 
the appropriate parametric or non-parametric hypothesis testing method. 
To test hypothesis H6, the answers from the fourth question on the training assessments were 
analyzed.  The fourth question is shown below. 
Figure 7. Fourth Question from CRDW Training Assessment 
 
A total of six potential outcomes could be selected by the trainee.  The mean and standard 
deviation for the number of potential outcomes were calculated for the pre- and 
post-assessments. Bar charts and boxplots were used to visualize the results from this question.  
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Then, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, the study researcher performed 
the appropriate parametric or non-parametric hypothesis testing method.   
To test hypothesis H7, the answers from the fifth question on the training assessments were 
analyzed.  The fifth question is shown below. 
Figure 8. Fifth Question from CRDW Training Assessment 
 
To process this data, each level of likelihood was assigned a numeric equivalent (“Very Likely” 
was 4, “Likely” was 3, “Unsure” was 2, “Unlikely” was 1, and “Very Unlikely” was 0).  The 
mean and standard deviation for the level of likelihood were calculated for the pre- and 
post-assessments. Bar charts and boxplots were used to visualize the results from this question.  
Because this assessment data uses an ordinal scale of measurement, hypothesis testing was 
performed using a non-parametric method (Wilcoxon matched-pairs signed-ranks test).   
4.6 Study Component #3:  Objective Measurement of Outcomes 
The third study component involved obtaining data from several BMI information systems to 
objectively measure outcomes achieved from the first two components.  As this component 
involves review of existing data, no recruitment procedures or goals were established for this 
component. 
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4.6.1 Research Procedure 
The third component involved the study researcher obtaining data from several BMI information 
systems to objectively measure outcomes achieved from the first two components.  Specifically, 
the following measures were obtained: 
 The number of CRDW access requests by individual and research project. 
 The number of CRDW training requests by research project team. 
 The number of trainees performing the CRDW activities related to their intended research 
outcomes. 
Currently, all requests for access and training for the CRDW are tracked within a system known 
as RISE.  These data have been tracked since 2016.  To determine if the awareness intervention 
was sufficient, the study researcher obtained RISE data for the number of requests for CRDW 
access and training during the study time period.  The study researcher used this data to 
determine if the intervention had increased the number of requests in comparison to prior years. 
To obtain the measurement of trainees performing the CRDW activities related to their intended 
research outcomes, the first step was reviewing the list of trainees who completed training during 
the study period.  The study researcher linked the trainees to their intended outcomes (e.g., 
protocol, poster presentation, and grant submission) identified in the completed feasibility or data 
release agreements.  In addition, the study researcher requested CRDW audit trail data for each 
of the trainees.  The study researcher reviewed the audit trail data to determine if trainees 
completed the appropriate actions within the CRDW to achieve their intended research 
outcomes.  For example, if the intended outcome was a grant submission, minimally, the 
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researcher would likely use the CRDW for a potential cohort of patients that could be included in 
the study.  For this use case, completion of a query within the CRDW was required to achieve 
the intended research outcome.  Individuals who completed the necessary CRDW actions within 
30 days of receiving training were identified as successfully completing the CRDW activities.  
This timeline aligned with the 30-day post-training assessment; as a result, no CRDW activities 
more than 30 days post-training were included as part of this study. 
4.6.2 Refinement of Procedure 
To determine if the objective measures for CRDW access and training requests were feasible, the 
study researcher obtained a sample of data from the RISE system for 2016, 2017, and 2018.  
Review of this sample confirmed that the necessary data for the applicable timeframes were 
available in RISE and could be used to obtain the number of requests and growth rates for 
analysis purposes.  Because the existing request documentation provided the necessary 
information for this study and to maintain consistency with historical data, no changes were 
made to this tracking for this study. 
To determine if the objective measure for CRDW activities was feasible, the study researcher 
obtained a sample of data for feasibility agreements, data release agreements, and audit trails 
from 2016, 2017, and 2018.  Review of this sample confirmed that the necessary data for the 
applicable timeframes were available and could be used to obtain the number of trainees that 
completed the CRDW activities related to their intended research outcomes.  Because the 
existing request documentation provided the necessary information for this study and to maintain 
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consistency with historical data, no changes were made to the CRDW feasibility agreements, 
data release agreements, and audit trails for this study. 
4.6.3 Data Processing and Analysis Procedure – Access Requests 
The purpose of measuring CRDW access requests was to test the following hypothesis: 
H3:  The growth rate of CRDW access requests for individuals and projects will increase during 
the awareness presentation intervention period in comparison to the growth rate from 
2016-2017 for the same time period. 
To test hypothesis H3, the CRDW access requests for the three-month study period (July 30 
through October 30) in 2016, 2017, and 2018 were exported from the RISE system into a 
Microsoft Excel file.  Within this data file, the key fields included the date of the request, the 
name and email of the principal investigator involved in the request, the project ID and name 
associated to the request, the name of the individual for whom access should be granted, and the 
type of tool for which access was granted.  Individuals could request access to one or both types 
of CRDW tools, and each type of tool was documented as a separate request.  As a result, an 
individual could have one or two records within the access dataset.  For example, if an individual 
requested access to the cohort tools (i2b2 and TriNetX), one record would exist for that 
individual’s request.  If the individual also requested access to Honest Broker, a second record 
would exist for that individual. 
To process this data, the study researcher first reviewed the file to identify any blanks, duplicated 
requests, or obvious errors (such as records that were outside of the study period).  If any issues 
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were found, they were documented and resolved by the researcher.  Next, the researcher 
identified the number of unique individuals requesting access.  If an individual had two requests 
(one for the cohort tools and one for Honest Broker), these records were combined to avoid 
double-counting the individuals.  The researcher also identified the number of unique projects 
associated to the access requests.  If a project ID was associated to more than one request 
(indicating multiple individuals requested access as part of that project), these requests were 
combined to avoid over counting an individual project.   
Once the study researcher identified unique records, the number of access requests by individual 
and by project were counted for each year (2016, 2017, and 2018).  The growth rates for 
2016-2017 and 2017-2018 were calculated using the formula: 
 𝐺𝑟𝑜𝑤𝑡ℎ 𝑅𝑎𝑡𝑒 ሺ%ሻ ൌ  ௒௘௔௥ ଶ ஼௢௨௡௧ି௒௘௔௥ ଵ ஼௢௨௡௧௒௘௔௥ ଵ ஼௢௨௡௧  𝑥 100 
The study researcher compared the calculated growth rates for 2016-2017 and 2017-2018 to 
determine if the hypothesized growth occurred. 
4.6.4 Data Processing and Analysis Procedure – Training Requests 
The purpose of measuring CRDW training requests was to test the following hypothesis: 
H4:  The growth rate of CRDW training requests for research project teams will increase during 
the awareness presentation intervention period in comparison to the growth rate from 
2016-2017 for the same time period. 
To test hypothesis H4, CRDW training requests for the three-month study period (July 30 
through October 30) in 2016, 2017, and 2018 were exported from the RISE system into a 
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Microsoft Excel file.  Within this data file, the key fields included the date of the request, the 
name and email of the principal investigator involved in the request, and the project ID and name 
associated to the request.  Each request within this dataset could involve one or more individuals 
from a project team.  In addition, a project team may request multiple training sessions.  As a 
result, the dataset could include multiple records for the same project. 
To process this data, the study researcher first reviewed the file to identify any blanks or obvious 
errors (such as records that were outside of the study period).  If any issues were found, they 
were documented and resolved by the researcher.  Next, the researcher identified the number of 
unique projects that had requested training.  If a project ID was associated to more than one 
request, these requests were combined to avoid over counting an individual project. 
Once the study researcher identified unique records, the number of training requests by project 
were counted for each year (2016, 2017, and 2018).  The growth rates for 2016-2017 and 2017-
2018 were calculated using the formula: 
 𝐺𝑟𝑜𝑤𝑡ℎ 𝑅𝑎𝑡𝑒 ሺ%ሻ ൌ  ௒௘௔௥ ଶ ஼௢௨௡௧ି௒௘௔௥ ଵ ஼௢௨௡௧௒௘௔௥ ଵ ஼௢௨௡௧  𝑥 100 
The study researcher compared the calculated growth rates for 2016-2017 and 2017-2018 to 
determine if the hypothesized growth occurred. 
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4.6.5 Data Processing and Analysis Procedure – Outcomes 
The purpose of measuring CRDW trainee completion of CRDW activities related to their 
intended research outcomes was to test the following hypothesis: 
H8:  Within 30 days of receiving CRDW training, at least 50% of individuals will complete the 
CRDW activities required to achieve their intended research outcomes. 
To test hypothesis H8, a mapping table was created linking the intended research outcomes 
identified on research teams’ Data Release Agreements with the appropriate actions within the 
CRDW.  Based on the expertise of the BMI Business Analyst, the following mapping table was 
created. 
Table 10. Mapping Table for Intended Research Outcomes and CRDW Actions 
Intended Outcome CRDW Actions 
Protocol Query (in i2b2 and/or TriNetX) 
Poster Presentation Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker) 
Grant Submission Query (in i2b2 and/or TriNetX) 
Abstract Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker) 
Manuscript Query (in i2b2 and/or TriNetX) and Extract (from Honest Broker) 
“Other” was also an option as an intended outcome.  The BMI Business Analyst reviewed any 
agreements in which this option was selected and determined the appropriate CRDW actions 
based on other information provided within the agreement. 
With the mapping complete, the next step was to obtain audit trail data from i2b2, TriNetX, and 
Honest Broker for each of the trainees who participated in study component #2 (assessment of 
CRDW training).  For each trainee, a listing of his/her activities within 30 days of his/her 
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training was aggregated from the separate CRDW tool audit trails, and then the listing was 
compared to the appropriate CRDW actions based on intended research outcome.  Trainees that 
completed the mapped CRDW actions within 30 days of his/her training were identified as 
successfully completing the CRDW activities. 
4.7 Study Component #4:  30-day Post-training Assessment 
The fourth and final component was designed to explore what factors may have influenced 
individuals’ decisions to adopt or reject use of the CRDW, as well as their achievement of 
outcomes.  The study researcher contacted volunteers identified at the end of the CRDW training 
sessions and asked them to complete a 30-day post-training assessment.  This assessment 
gathered quantitative and qualitative information about individuals’ perceptions of CRDW use, 
which was used to explore potential reasons for CRDW adoption or rejection, as well as 
completion or lack of completion of the CRDW activities related to their intended research 
outcomes. 
Recruitment for this study component occurred at the end of the CRDW training sessions.  
Following the recruitment protocol, at the end of each CRDW training session, the BMI Business 
Analyst asked each trainee if he/she was willing to participate in a 30-day post-training 
assessment.  If the trainee declined, the BMI Business Analyst documented the trainee’s name 
and date of training and indicated that the trainee would not participate.  This documentation 
ensured the trainee was not inadvertently contacted for the last component of this study and that 
a complete list of trainees was available at the end of the study.  If the trainee consented, the 
BMI Business Analyst documented the trainee’s name and date of training and indicated the 
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trainee’s preferred follow-up method (in-person interview, phone interview, or email with an 
electronic survey) and contact information.  The goal was to have 10% of trainees complete the 
30-day post-training assessment.  This goal was based on previous response rates for similar 
interview and survey data collection procedures. 
4.7.1 Research Procedure 
During the study, the study researcher accessed the list of trainees.  For trainees who consented 
to be contacted for a 30-day post-training assessment, the study researcher contacted each trainee 
based on the identified preferred follow-up method. 
For individuals who indicated a preference for an electronic survey, a link to the survey was sent 
to the individual via email.  The first email contact occurred within 30-38 days post-training.  If 
the survey was not completed within one week after the first contact, one additional follow-up 
email was sent to remind the trainee to complete the survey. 
For individuals who indicated a preference for an in-person or phone interview, the study 
researcher contacted the trainee using his/her preferred contact method to schedule an 
appropriate date, time, and location (if needed).  The first contact occurred within 30-38 days 
post-training.  If needed based on lack of response, a second contact occurred one week after the 
initial contact.  For these interviews, the survey researcher asked the same questions that were 
provided on the electronic survey.  Trainees were provided the response scales for each question 
to ensure consistency in responses.   
85 
All responses completed within 30-45 days post-training were included in this study component.  
In addition, responses to the interviews and electronic surveys were combined into a single 
dataset for review and analysis. 
4.7.2 Assessment Tool Development 
The goal of the 30-day post-training assessment was to gather quantitative and qualitative 
information about individuals’ perceptions of CRDW use, which could be used to explore 
potential reasons for achievement or lack of achievement of outcomes.  As a result, the study 
researcher developed an assessment tool to gather information about key components the 
technology adoption frameworks identify as strong determinants of use. 
In the first section of the assessment tool, the individual was asked if he/she used the CRDW.  If 
the answer to this question was yes, further questions asked about the activities performed, the 
perceptions of ease of use of the CRDW tools, and how the individual used the data (or plans to 
use the data).  The goal of this section was to document actual use, perceived ease of use, and 
perceived usefulness of the CRDW. 
The second section of the assessment tool determined if the individual requested support from 
the BMI department regarding the CRDW.  Because support was considered an important factor 
in technology adoption, the goal of this question was to understand if individuals were using the 
available support. 
The third section of the assessment tools asked for individual perceptions of the potential 
benefits or barriers to using the CRDW.  Previous technology adoption framework research 
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provided example survey items to measure factors influencing technology adoption.  The study 
researcher adapted these items to reference the CRDW and related tools.  The goal of this section 
was to gather information that could be used to explore potential reasons for completion or lack 
of completion of the CRDW activities related to their intended research outcomes. 
The fourth section addressed an individual’s self-reported likelihood to use the CRDW, which 
was similar to the question that was included in the first two study component assessments.  The 
purpose of this question was to obtain an indication of the individual’s attitude toward the 
CRDW (a key component of DOI theory and the TAM model) and gain some qualitative 
information for anyone indicating a low likelihood of use. 
The final section allowed the user to provide any additional comments about his/her experience 
with the CRDW.  The goal of this section was to capture information that individuals wanted to 
provide but were not covered in the previous sections. 
The study researcher documented this assessment tool in a Microsoft Word template that could 
be used to record the results from in-person and phone interviews.  Additionally, the tool was 
built in an electronic survey tool (REDCap) for the emailed surveys. 
4.7.3 Refinement of Procedure and Assessment Tool 
The study researcher had the content of the assessment tool reviewed by an individual with 
expertise in survey design.  This review resulted in some minor wording changes, as well as a 
format change to the third section.  The written and electronic forms for the assessment were also 
reviewed with the BMI Business Analyst for content and flow.  This review resulted in some 
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minor wording changes.  No issues with survey flow were identified.  A copy of the revised 
assessment is provided in Appendix E: 30-day Post-training Assessment Tool. 
Because the study researcher has conducted similar research procedures for other projects, no 
additional refinement activities were performed for this research procedure. 
4.7.4 Data Processing and Analysis Procedure 
The purpose of study component #4 was to investigate potential factors that influence trainees’ 
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days 
of their original training. 
The first section of the assessment gathered information about individual use of the CRDW.  The 
questions in this section are shown below. 
Figure 9. 30-day Post-training Assessment – Section 1 Questions 
  
If the answer to the previous question is Yes, the following additional questions appear: 
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To process and analyze the data from the use of the CRDW question, the study researcher 
obtained a count of each response and calculated the percentage of participating trainees 
indicating they had used the CRDW since their training sessions.   
If the trainee indicated that he/she had used the CRDW, then he/she would see the subsequent 
three questions.  For the first and third subsequent question, trainees could select more than one 
option.  As a result, the study researcher counted the number of responses for each option and 
calculated the percentage of participating trainees indicating each option. 
For the second subsequent question in this section, the number of options for answers were 
collapsed to provide directional information due to the relatively small sample size in relation to 
the number of options provided as answers.  The options for rating of the ease of use of CRDW 
tools included “Very easy to use,” “Easy to use,” “Difficult to use,” and “Very difficult to use.”  
These ease of use ratings were collapsed into “Easy to use” (for “Very easy to use” and “Easy to 
use”) and “Difficult to use” (for “Difficult to use” and “Very difficult to use”) to provide a 
clearer summary of assessment answers.  The study researcher counted the responses for each 
rating and then determined any directional trends within the responses. 
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The second section of the assessment gathered information about requests for CRDW support.  
The questions in this section are shown below. 
Figure 10. 30-day Post-training Assessment – Section 2 Questions 
  
If the answer to the previous question is Yes, the following additional question appears: 
  
To process and analyze the data from the CRDW support question, the study researcher obtained 
a count of each response and calculated the percentage of participating trainees indicating they 
had requested CRDW support since training.  For the trainees indicating that they had requested 
support, they would see the subsequent question.  The study researcher reviewed these responses 
to determine which individuals were contacted for CRDW support. 
The third section of the assessment obtained individual perceptions of the potential benefits and 
barriers to using the CRDW.  The questions in this section are shown below. 
Figure 11. 30-day Post-training Assessment – Section 3 Questions 
 
90 
To analyze the data from this section of the assessment, the study researcher collapsed the 
number of options for answers to provide directional information due to the relatively small 
sample size in relation to the number of options provided as answers.  The options included 
“Strongly Agree,” “Somewhat Agree,” “Neither Agree nor Disagree,” “Somewhat Disagree,” 
and “Strongly Disagree.”  These options were collapsed into “Agree” (for “Strongly Agree” and 
“Somewhat Agree”), “Neutral” (for “Neither Agree nor Disagree”), and “Disagree” (for 
“Somewhat Disagree” and “Strongly Disagree”) to provide a clearer summary of assessment 
answers.  The study researcher counted the responses for each rating and then determined any 
directional trends within the responses.  The results were also visualized using bar charts 
organized by positively and negatively worded statements. 
The fourth section of the assessment obtained an individual’s self-reported likelihood to use the 
CRDW.  The question in this section is shown below. 
Figure 12. 30-day Post-training Assessment – Section 4 Question 
 
To analyze the data from this section of the assessment, the study researcher collapsed the 
number of options for answers to provide directional information due to the relatively small 
sample size in relation to the number of options provided as answers.  The options included 
“Very Likely,” “Likely,” “Unsure,” “Unlikely,” and “Very Unlikely.”  These options were 
collapsed into “Likely” (for “Very Likely” and “Likely”), “Unsure” (for “Unsure”), and 
“Unlikely” (for “Unlikely” and “Very Unlikely”) to provide a clearer summary of assessment 
answers.  The study researcher counted the responses for each rating and then determined any 
directional trends within the responses.   
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The fifth and final section of the assessment allowed the individual to provide any additional 
comments about his/her experience with the CRDW.  The question in this section is shown 
below. 
Figure 13. 30-day Post-training Assessment – Section 5 Question 
 
The study researcher reviewed any responses from this section and included them as part of the 
analysis for the appropriate section.  For example, if the individual included a comment that 
he/she was unable to use the CRDW since training, the study researcher reviewed this comment 
in the context of the other assessment answers.  Due to the relatively small sample size for this 
study component, no thematic analysis was performed based on the comments from this section 
of the assessment. 
4.8 Record Retention 
For the pre- and post-assessments, as well as the 30-day post-training assessment, the study 
researcher entered the results (answers to each assessment or follow-up question) into the 
REDCap system hosted at Medical College of Wisconsin. REDCap (Research Electronic Data 
Capture) is a secure, web-based application designed to support data capture for research studies, 
providing 1) an intuitive interface for validated data entry; 2) audit trails for tracking data 
manipulation and export procedures; 3) automated export procedures for seamless data 
downloads to common statistical packages; and 4) procedures for importing data from external 
sources.125,126  In addition, the study researcher entered the results into a Microsoft Excel 
spreadsheet stored on an encrypted hard drive.  This second copy served as confirmation of the 
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REDCap data entry and provided a backup should the REDCap data be lost or compromised.  
The study researcher retained the original paper records (such as completed pre- and post-
assessments) in a secure location. 
Additional electronic documentation generated during the study was stored in an MCW box.com 
folder shared by the BMI Business Analyst and the study researcher.  This additional 
documentation could include, but was not limited to, data reports for the objective measurements 
study component and backups of any Microsoft Excel spreadsheets used for data capture and/or 
analysis.  For backup purposes, the study researcher regularly copied these files to an encrypted 
external hard drive owned by the researcher. 
4.9 Researcher Role and Experience 
For this project, the study researcher’s role was as principal investigator and evaluator for each 
of the study components.  Specifically, this included the creation of assessment tools, review of 
data obtained from related CRDW data sources (such as audit trails and the RISE system), and 
completion of the 30-day post-training assessments.  These activities were feasible for the study 
researcher to complete based on her background and professional experience. 
The study researcher for this project has been a member of the CTSI since 2016 and has served 
as an advisor for several CTSI Quality and Efficiency module projects, including two projects 
for the BMI department.  These experiences have allowed the study researcher to understand the 
CTSI structure, learn about the BMI department, and become acquainted with key individuals 
within the CTSI. 
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In addition, the study researcher has more than twelve years of professional teaching experience 
in higher education, including four years in a program director position.  During this time, the 
study researcher has developed more than 20 courses, redesigned the curricula for two degree 
programs, and gained valuable insights by working with a professional instructional designer and 
completing coursework in adult education.  As a result, the study researcher has deep experience 
developing course learning objectives and assessments and knowledge of adult education 
principles. 
Finally, the study researcher spent more than a decade in information-technology related roles 
leading, managing, and supporting individuals and systems within three of the CTSI partner 
organizations (BCW, Froedtert Hospital, and MCW).  This experience includes more than seven 
years implementing, supporting, and maintaining EHR-related software, interfaces, security, and 
infrastructure.  Experience gained leading enterprise EHR implementation projects has provided 
the study researcher with critical, firsthand experience with technology adoption at both 
individual and organization levels. 
4.10 Institutional Review Board (IRB) 
This study was approved by the Medical College of Wisconsin/Froedtert Hospital Institutional 
Review Board (IRB) in accordance with 45 CFR 46.111 by expedited review, Categories 5 and 
7, as a minimal risk study (see Appendix A: Institutional Review Board Approval Letter).  As 
part of existing IRB reliance master agreements, this approval was granted for the Medical 
College of Wisconsin – Milwaukee campus, Milwaukee School of Engineering, and University 
of Wisconsin-Milwaukee. 
94 
4.11 Timeline and Budget 
The study period timeline was 32 weeks, with most of the data collection and analysis for this 
study occurring from August 2018 through November 2018.  This timeline was chosen for 
several reasons.  First, many new researchers, residents, and students began working at CTSI 
partner institutions during this timeframe.  Having the interventions occur during this time period 
provided the greatest opportunity to involve a diverse cohort of individuals.  Second, this 
timeframe allowed the study to be completed prior to the submission of the CTSA renewal 
proposal, which is due in April 2019.  Results from this study may be included within this 
renewal packet as evidence of goal achievement.  Finally, this timeline allowed sufficient time to 
assess the outcomes of the awareness presentation and training, but was short enough to 
minimize negative effects should these components result in ineffective or detrimental results.   
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Below is the high-level timeline for this study. 
Table 11. High-level Timeline for the Study 
 
From a budget perspective, the efforts of Bradley Taylor and Kristen Osinski from the BMI 
department, as well as the use of REDCap software, were supported by the National Center for 
Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436.  
The efforts of Dr. Luo (UWM advisor) and committee members (Dr. Cisler, Dr. Kate, Dr. 
Patrick, and Dr. Payne) were provided at no cost to the project.  The efforts of Katie McCarthy 
were not monetarily compensated.  The study participants were not compensated as part of this 
study.  As a result, no project budget allocation was needed for resources or participants. 
This study involved procurement of office supplies such as pens, paper, envelopes, and printer 
ink.  The estimate for these costs was $500 and was provided by the study researcher.  No other 
costs were associated to this project. 
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4.12 Study Methodology Limitations 
Although this study has several strengths with the potential to make an important contribution to 
literature regarding data warehouse adoption and use for clinical and translational research 
purposes, there are potential methodology limitations that need to be noted.   
First, although the CTSA hubs share common CRDW tools, such as i2b2, each CTSA hub has 
variation in data warehouse implementation.  For example, the Honest Broker tool used at the 
CTSI is unique to that CTSI.  As a result, further work would be needed to determine if these 
study components could be generalized for use at other CTSA hubs, especially in relation to the 
objective measures used.   
Second, the 30-day post-training assessment population is based on volunteers identified at the 
completion of CRDW training sessions.  A potential exists that volunteer bias could exist within 
this cohort.  For example, only those individuals who feel confident in their use of the CRDW 
may volunteer, which may cause results showing more activity than the overall trainee 
population.  Additionally, knowing that a 30-day post-training assessment exists may change the 
behaviors of all trainees in relation to their use of the CRDW.  For instance, trainees may rush to 
complete their work within 30 days of training even if this would not be their normal behavior.   
Finally, the 30-day post-training assessment focuses on individuals receiving CRDW training 
and does not attempt to contact individuals who received access to the CRDW but did not 
receive training.  While focusing on individuals receiving training is reasonable based on the 
desire to explore the link between training and completion of CRDW activities, it is possible that 
choosing this population could result in bias (such as individuals who receive training are 
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generally less comfortable with technology than those who choose not to receive training).  As a 
result of these limitations, care should be used when interpreting and attempting to generalize the 
results of this study.  
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CHAPTER 5: RESULTS 
Within this chapter, the results of each of the study components are presented, including the 
acceptance or rejection of each of the study’s hypotheses. 
5.1 Study Procedures and Timeline 
After receiving IRB approval on July 26, 2018, data collection for this study occurred according 
to the project timeline.  Throughout the study, no deviations from the procedures described in the 
previous chapter were encountered.   
5.2 Study Component #1:  Awareness Intervention 
During the study period, seven presentations were held with a total of 54 participants attending.  
Based on informal introductions occurring prior to the presentations, participants included 
representatives from four of the eight CTSI partner organizations (CHW, MCW, MSOE, and 
UWM) and held a variety of research-related roles (including investigators, academic faculty, 
research coordinators, research administrators, laboratory management and staff, fellows, 
medical students, and graduate students).   
Of the 54 participants, a total of 50 participants attempted the pre- and post-assessments.  Of 
these 50 assessment pairs, one was found to be incomplete and was removed from the sample.  
As a result, a total of 49 participants (91%) successfully completed the presentation pre- and 
post-assessments, which exceeded the minimum sample size of 40 completed assessment pairs 
originally proposed for this study. 
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The purpose of study component #1 was to test the following hypotheses: 
H1:  Awareness presentations will increase the average number of correct answers from the 
pre-assessment to the post-assessment. 
H2:  Awareness presentations will increase the average self-reported level of likelihood to use 
from the pre-assessment to the post-assessment. 
Below is a summary of the results for these hypotheses. 
5.2.1 Hypothesis H1 Results – Correct Answers 
To test hypothesis H1, the answers from the first three questions on the awareness presentation 
assessments were analyzed.  The maximum number of potential correct answers for one 
assessment was eleven.  Within the dataset, the total number of correct answers ranged from four 
to eleven.  In the pre-assessments, the mean (standard deviation) was 7.8 (1.6) total correct 
answers.  In the post-assessments, the mean (standard deviation) was 9.7 (1.2) total correct 
answers. 
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The figure below shows the frequency of the number of correct answers for the pre-assessment 
and post-assessment.   
Figure 14. Correct Answers for Awareness Presentation Assessments 
 
As shown in the figure above, the number of correct answers for the individual questions 1, 2, 
and 3 increased from the pre-assessment (before the awareness presentation) to the 
post-assessment (after the awareness presentation).  The total number of correct answers for this 
section also increased from the pre-assessment to the post-assessment.  This supports hypothesis 
H1. 
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To visualize the change in the median number of total correct answers from pre-assessment to 
post-assessment, a boxplot was created (and is shown below). 
Figure 15. Boxplot of Total Correct Answers for Awareness Presentation Assessments 
 
As shown in the figure above, the median number of total correct answers from the 
pre-assessments was 8 correct answers.  The median number of total correct answers from the 
post-assessments was 10 correct answers, which is an increase of two correct answers from the 
pre-assessment.  This supports hypothesis H1. 
Next, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, normality could not be 
assumed for this data; therefore, hypothesis testing was performed using a non-parametric 
method (Wilcoxon matched-pairs signed-ranks test).  The Wilcoxon matched-pairs signed-ranks 
test indicated that the post-assessment scores were statistically significantly higher than 
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pre-assessment scores (Wilcoxon T(37) = 241, p < 0.000, one-tailed test).  As a result, 
hypothesis H1 was accepted. 
5.2.2 Hypothesis H2 Results – Likelihood to Use 
To test hypothesis H2, the answers from the fourth question on the awareness presentation 
assessments were analyzed.  The possible options for this question were “Very likely” to “Very 
unlikely.”  Within the dataset, answers ranged from “Very likely” to “Unlikely.”  No participants 
selected “Very unlikely” in response to this question.  In the pre-assessments, the mean (standard 
deviation) was a 2.4 (0.9) level of likelihood.  In the post-assessments, the mean (standard 
deviation) was a 3.0 (1.0) level of likelihood.   
The figure below shows the frequency of the levels of likelihood for the pre-assessment and 
post-assessment. 
Figure 16. Levels of Likelihood for Awareness Presentation Assessments 
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As shown in the figure above, the majority of participants indicated they were unsure if they 
would use the CRDW in the pre-assessments (prior to the awareness presentations).  In the 
post-assessments (after the awareness presentations), the majority of participants indicated that 
they were very likely or likely to use the CRDW, which indicates an increase in level of 
likelihood from the pre-assessments to the post-assessments.  This supports hypothesis H2. 
To visualize the change in the median level of likelihood to use from pre-assessment to 
post-assessment, a boxplot was created (and is shown below). 
Figure 17. Boxplot of Levels of Likelihood for Awareness Presentation Assessments 
 
As shown in the figure above, the median level of likelihood was 2 (which is the numeric value 
of the “Unsure” option) in the pre-assessments.  In the post-assessments, the median level of 
likelihood was 3 (which is the numeric equivalent of the “Likely” option).  This increase 
supports hypothesis H2. 
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The Wilcoxon matched-pairs signed-ranks test indicated that the post-assessment likelihood 
levels were statistically significantly higher than pre-assessment likelihood levels (Wilcoxon 
T(9.5) = 83, p < 0.000, one-tailed test).  As a result, hypothesis H2 was accepted. 
5.3 Study Component #2:  Assessment of CRDW Training 
During the study period, eight training sessions were held with a total of 17 trainees attending.  
Due to the anonymity of the awareness presentation participants, it is unknown if any of these 
trainees attended the awareness presentations prior to receiving training.  Of the 17 trainees, all 
successfully completed the training pre- and post-assessments, which exceeds the 75% 
participation rate originally proposed for this study. 
The purpose of study component #2 was to test the following hypotheses: 
H5:  CRDW training will increase the average number of correct answers from the pre-
assessment to the post-assessment. 
H6:  CRDW training will increase the average number of identified potential outcomes from the 
pre-assessment to the post-assessment. 
H7:  CRDW training will increase the average self-reported level of likelihood to use from the 
pre-assessment to the post-assessment. 
Below is a summary of the results for these hypotheses. 
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5.3.1 Hypothesis H5 Results – Correct Answers 
To test hypothesis H5, the answers from the first three questions on the training assessments 
were analyzed.  The maximum number of potential correct answers for one assessment was 
eleven.  Within the dataset, the total number of correct answers ranged from three to eleven.  In 
the pre-assessments, the mean (standard deviation) was 7.6 (2.4) total correct answers.  In the 
post-assessments, the mean (standard deviation) was 9.3 (1.4) total correct answers. 
The figure below shows the frequency of the number of correct answers for the pre-assessment 
and post-assessment.   
Figure 18. Correct Answers for CRDW Training Assessments 
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As shown in the figure above, the number of correct answers for the individual questions 1, 2, 
and 3 increased from the pre-assessment (before the training session) to the post-assessment 
(after the training session).  The total number of correct answers for this section also increased 
from the pre-assessment to the post-assessment.  This supports hypothesis H5. 
To visualize the change in the median number of total correct answers from pre-assessment to 
post-assessment, a boxplot was created (and is shown below). 
Figure 19. Boxplot of Total Correct Answers for CRDW Training Assessments 
 
As shown in the figure above, the median number of total correct answers from the 
pre-assessments was 8 correct answers.  The median number of total correct answers from the 
post-assessments was 9 correct answers, which is an increase of one correct answer from the 
pre-assessment.  This supports hypothesis H5. 
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Next, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, normality could not be 
assumed for this data; therefore, hypothesis testing was performed using a non-parametric 
method (Wilcoxon matched-pairs signed-ranks test).  The Wilcoxon matched-pairs signed-ranks 
test indicated that the post-assessment scores were statistically significantly higher than pre-
assessment scores (Wilcoxon T(8.5) = 21, p = 0.005, one-tailed test).  As a result, hypothesis H5 
was accepted. 
5.3.2 Hypothesis H6 Results – Potential Outcomes 
To test hypothesis H6, the answers from the fourth question on the training assessments were 
analyzed.  A total of six potential outcomes could be selected by the trainee.  Within the dataset, 
the number of potential outcomes selected ranged from one outcome to five outcomes.  In the 
pre-assessments, the mean (standard deviation) was 2.4 (1.4) potential outcomes.  In the 
post-assessments, the mean (standard deviation) was 2.2 (1.3) potential outcomes. 
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The figure below shows the frequency of the number of potential outcomes for the 
pre-assessment and post-assessment. 
Figure 20. Number of Potential Outcomes for Training Assessments 
 
Based on this figure, the majority of trainees indicated one potential outcome during the 
pre-assessment (before the training session).  In the post-assessment (after the training session), 
the majority of trainees indicated one potential outcome.  As a result, an increase in potential 
outcomes identified did not occur.  This does not support hypothesis H6. 
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To visualize the change in the median number of potential outcomes from pre-assessment to 
post-assessment, a boxplot was created (and is shown below). 
Figure 21. Boxplot of Number of Potential Outcomes for Training Assessments 
 
As shown above, the boxplots for the pre-assessment and post-assessment show no difference in 
the number of potential outcomes identified, which does not support hypothesis H6. 
Next, the study researcher tested the normality of the data using Q-Q plots and the results of the 
Shapiro-Wilk normality tests.  Based on the results of these tests, normality could not be 
assumed for this data; therefore, hypothesis testing was performed using a non-parametric 
method (Wilcoxon matched-pairs signed-ranks test).  The Wilcoxon matched-pairs signed-ranks 
test indicated that the post-assessment potential outcomes were not statistically significantly 
different than pre-assessment potential outcomes (Wilcoxon T(9) = 0, p = 0.824, two-tailed test).  
As a result, hypothesis H6 was rejected. 
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5.3.3 Hypothesis H7 Results – Likelihood to Use 
To test hypothesis H7, the answers from the fifth question on the training assessments were 
analyzed.  The possible options for this question were “Very likely” to “Very unlikely.”  Within 
the dataset, answers ranged from “Very likely” to “Unsure.”  No participants selected “Unlikely” 
or “Very unlikely” in response to this question.  In the pre-assessments, the mean (standard 
deviation) was a 3.0 (0.7) level of likelihood.  In the post-assessments, the mean (standard 
deviation) was a 3.6 (0.6) level of likelihood. 
The figure below shows the frequency of the levels of likelihood for the pre-assessment and 
post-assessment.  
Figure 22. Levels of Likelihood for Training Assessments 
 
As shown in the figure above, the majority of participants indicated they were likely to use the 
CRDW in the pre-assessments (prior to the training sessions).  In the post-assessments (after the 
training sessions), the majority of participants indicated that they were very likely to use the 
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CRDW, which indicates an increase in level of likelihood from the pre-assessments to the 
post-assessments.  This supports hypothesis H7. 
To visualize the change in the median level of likelihood to use from pre-assessment to 
post-assessment, a boxplot was created (and is shown below). 
Figure 23. Boxplot of Levels of Likelihood for Training Assessments 
 
As shown in the figure above, the median level of likelihood was 3 (which is the numeric value 
of the “Likely” option) in the pre-assessments.  In the post-assessments, the median level of 
likelihood was 4 (which is the numeric equivalent of the “Very Likely” option).  This increase 
supports hypothesis H7. 
The Wilcoxon matched-pairs signed-ranks test indicated that the post-assessment likelihood 
levels were statistically significantly higher than pre-assessment likelihood levels (Wilcoxon 
T(3.5) = 8, p = 0.011, one-tailed test).  As a result, hypothesis H7 was accepted. 
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5.4 Study Component #3:  Objective Measurement of Outcomes 
Study component #3 involved the objective measurement of CRDW access requests, CRDW 
training requests, and trainee completion of CRDW activities related to their intended research 
outcomes.  Below is a summary of the results for these measurements and related hypotheses. 
5.4.1 Hypothesis H3 Results – Access Requests 
The purpose of measuring CRDW access requests was to test the following hypothesis: 
H3:  The growth rate of CRDW access requests for individuals and projects will increase during 
the awareness presentation intervention period in comparison to the growth rate from 
2016-2017 for the same time period. 
The following table summarizes the number of individuals requesting access to the CRDW 
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated 
year-to-year. 
Table 12. CRDW Access Requests by Individual in 2016, 2017, and 2018 
2016 2017 2018 Growth Rate (2016-2017) 
Growth Rate 
(2017-2018) 
26 61 39 135% -36% 
 
Based on this analysis, the growth rate of access requests by individual decreased by 36% during 
the study period compared to the previous year.   
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The following table summarizes the number of projects associated to CRDW access requests 
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated 
year-to-year. 
Table 13. CRDW Access Requests by Project in 2016, 2017, and 2018 
2016 2017 2018 Growth Rate (2016-2017) 
Growth Rate 
(2017-2018) 
15 31 18 107% -42% 
 
Based on this analysis, the growth rate of access requests by project decreased by 42% during the 
study period compared to the previous year.   
Because the growth rate for individual and project access requests decreased during the study 
period instead of increasing as hypothesized, hypothesis H3 was rejected. 
5.4.2 Hypothesis H4 Results – Training Requests 
The purpose of measuring CRDW training requests was to test the following hypothesis: 
H4:  The growth rate of CRDW training requests for research project teams will increase during 
the awareness presentation intervention period in comparison to the growth rate from 
2016-2017 for the same time period. 
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The following table summarizes the number of projects associated to CRDW training requests 
during the study period in 2016, 2017, and 2018, as well as the growth rate calculated 
year-to-year. 
Table 14. CRDW Training Requests by Project in 2016, 2017, and 2018 
2016 2017 2018 Growth Rate (2016-2017) 
Growth Rate 
(2017-2018) 
8 20 9 150% -55% 
 
Note that nine training sessions were documented in RISE during the study period in 2018, but 
only eight training sessions were part of the CRDW training assessment (study component #2) 
that occurred during this same period.  This discrepancy was the result of a refresher training 
session that was held during the study period for an individual that previously received CRDW 
training.  Although this training session did not meet the criteria to be included in study 
component #2 (assessment of CRDW training), this training session was included in the RISE 
records as a training request (as RISE training requests include all types of CRDW training 
provided). 
Based on this analysis, the growth rate of training requests by project decreased by 55% during 
the study period compared to the previous year.  Because the growth rate for project team 
training requests decreased during the study period instead of increasing as hypothesized, 
hypothesis H4 was rejected. 
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5.4.3 Hypothesis H8 Results – Outcomes 
The purpose of measuring trainee completion of CRDW activities related to their intended 
research outcomes was to test the following hypothesis: 
H8:  Within 30 days of receiving CRDW training, at least 50% of individuals will complete the 
CRDW activities required to achieve their intended research outcomes. 
Of the 17 trainees involved in study component #2 (assessment of CRDW training), four 
individuals (24%) completed the appropriate CRDW actions mapped to their identified intended 
research outcomes.  Because less than 50% of individuals receiving training completed the 
CRDW activities required to achieve their identified research intended outcomes, hypothesis H8 
was rejected. 
5.5 Study Component #4:  30-day Post-training Assessment 
The purpose of study component #4 was to investigate potential factors that influence trainees’ 
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days 
of their original training.  Of the 17 trainees that participated in study component #2 (assessment 
of CRDW training), 16 trainees (94%) consented to be contacted for a 30-day post-training 
assessment.  Of the consenting trainees, a total of ten participants successfully completed the 
assessment within 30-45 days of their original training, resulting in a 59% participation rate.  
This participation rate exceeds the 10% rate originally proposed for this study component.   
Additionally, of the trainees who completed the 30-day post-training assessment, two trainees 
(20%) completed the CRDW activities related to their intended research outcomes and eight 
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trainees (80%) did not complete the CRDW activities related to their intended research outcomes 
in study component #3 (objective measurement of outcomes).  This achievement ratio is similar 
to the ratio for all the trainees who participated in this study. 
Although the participation rate was higher than originally proposed, the sample size is relatively 
small in relation to the number of options provided as answers.  For example, the options for 
rating of the ease of use of CRDW tools included “Very easy to use,” “Easy to use,” “Difficult to 
use,” and “Very difficult to use.”  As a result, the number of options were collapsed to provide 
directional information as previously described. 
5.5.1 Section #1:  Use of the CRDW Tools 
In the first section of the assessment, individuals were asked if they used the CRDW.  If so, 
further questions asked about the activities performed, the ease of use of the CRDW tools, and 
how the data has been (or will be) used.  Six of the ten trainees (60%) indicated that they had 
used the CRDW tools since receiving training and, therefore answered three additional questions 
related to CRDW use.   
The first question asked trainees to identify the activities they completed using the CRDW tools.  
Six trainees (100%) had obtained a count of patients within a particular cohort.  One trainee also 
analyzed the demographic distribution and extracted data tables for a patient set. 
The second question asked trainees to rate the ease of use of each of the CRDW tools.  Based on 
the responses to this question, the majority of trainees found i2b2 and Honest Broker easy to use, 
while trainees were evenly split on the ease of use of TriNetX. 
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The third question asked trainees how they have used or plan to use the data obtained from the 
CRDW.  Trainees were allowed to select one or more of five possible plans.  The most common 
selection was using the data for cohort discovery (three trainees), closely followed by using the 
data for prospective studies (two trainees) and using the data for retrospective studies (two 
trainees).   
5.5.2 Section #2:  Requesting Support 
In the second section of the assessment, trainees were asked if they contacted the BMI 
department to receive CRDW support.  Four trainees (40%) indicated that they had requested 
support from the BMI department.  Of these trainees, all contacted the BMI Business Analyst to 
obtain this support.  Two of the four trainees also provided information within the comments 
section of the assessment, identifying the BMI Business Analyst as being an effective resource 
and phenomenal in providing education and support. 
5.5.3 Section #3:  Benefits and Barriers to CRDW Use 
In the third section of the assessment, trainees were asked about their perceptions of potential 
benefits and barriers to using the CRDW.  The figure below shows the level of agreement for 
each of these statements.  The left column of graphs shows the results for the three positively 
phrased statements; the right column shows the results for the three negatively phrased 
statements.  
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Figure 24. Responses to Benefits and Barriers Statements 
  
5.5.4 Section #4:  Likelihood to Use the CRDW 
In the fourth section of the assessment, trainees were asked about their level of likelihood to use 
the CRDW for future clinical research.  Eight trainees (80%) reported being likely to use the 
CRDW again. 
One trainee (10%) reported being unsure of using the CRDW in the future.  In the comments 
section of the assessment, this trainee identified that he/she had not yet had an opportunity to 
access the data within the CRDW, but felt the CRDW would be beneficial in the future.  This 
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trainee expressed a concern that receiving training and not using it immediately may present 
some problems, but the trainee also identified that he/she knew how to reach out for support. 
One trainee (10%) reported being unlikely to use the CRDW in the future.  In this trainee’s 
assessment responses, he/she identified lack of support, difficulty using the Honest Broker tool, 
and lack of availability of needed data within the CRDW as potential barriers.  The trainee also 
somewhat disagreed with the statement that the CRDW was beneficial for his/her work.  The 
trainee did not request support from the BMI department.  The trainee did not provide any 
further comments within his/her assessment responses. 
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CHAPTER 6: DISCUSSION 
The purpose of this study was to assess and measure the impact of raising awareness and 
providing training on the completion of CRDW activities related to intended research outcomes.  
This study also explored potential factors that influenced the completion of CRDW activities.  
Specifically, three research questions were examined: 
Q1:  Is delivering a 20-minute presentation regarding CRDW basic functions and processes a 
sufficient intervention to raise awareness of the CRDW for clinical and translational research 
purposes? 
Q2:  Does existing CRDW training provide sufficient information for trainees to perform the 
CRDW activities related to their intended research outcomes? 
Q3:  What potential factors influence trainees’ use of the CRDW for clinical and translational 
research purposes? 
Four study components were used to investigate these questions.  The previous chapter presented 
detailed results from each of these components.  This chapter will provide an overall summary of 
the findings, the interpretation of the findings by research question, the limitations of the study, 
and the implications of the findings for future research. 
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6.1 Summary of Study Findings 
The following table presents the eight hypotheses tested in this study and indicates if the 
hypotheses were supported based on the findings from each study component. 
Table 15. Assessment of Study Hypotheses 
Hypothesis Hypothesis Supported 
Research Question #1 
H1:  Awareness presentations will increase the average number of correct 
answers from the pre-assessment to the post-assessment. 
Yes 
H2:  Awareness presentations will increase the average self-reported level 
of likelihood to use from the pre-assessment to the post-assessment. 
Yes 
H3:  The growth rate of CRDW access requests for individuals and 
projects will increase during the awareness presentation intervention 
period in comparison to the growth rate from 2016-2017 for the same time 
period. 
No 
H4:  The growth rate of CRDW training requests for research project 
teams will increase during the awareness presentation intervention period 
in comparison to the growth rate from 2016-2017 for the same time 
period. 
No 
Research Question #2 
H5:  CRDW training will increase the average number of correct answers 
from the pre-assessment to the post-assessment. 
Yes 
H6:  CRDW training will increase the average number of identified 
potential outcomes from the pre-assessment to the post-assessment. 
No 
H7:  CRDW training will increase the average self-reported level of 
likelihood to use from the pre-assessment to the post-assessment. 
Yes 
H8:  Within 30 days of receiving CRDW training, at least 50% of 
individuals will complete the CRDW activities required to achieve their 
intended research outcomes. 
No 
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6.2 Research Question #1:  Raising Awareness of the CRDW 
The approach of this study mirrored the five innovation-decision stages identified in the DOI 
theory.  As a result, research question #1 (Q1) was used to determine if a specific intervention 
(presentation) to raise awareness was successful in increasing knowledge of the CRDW, as well 
as moving individuals into the persuasion stage, where individuals actively seek out information 
regarding the CRDW. 
Based on the results for research hypotheses H1 and H2, the presentation did increase 
participants’ knowledge of the CRDW, as well as their self-reported level of likelihood to use the 
CRDW, both of which would indicate a successful awareness intervention.  In reviewing the 
results of hypotheses H3 and H4, the number of CRDW access and training requests did not 
increase as anticipated, but instead decreased during the study period when compared to previous 
years.  As a result, while the knowledge stage was reached, the persuasion stage was not reached 
during the study period. 
One possible explanation is that the awareness intervention may have been successful (as 
indicated by the increase in knowledge and likelihood to use), but the timeline for the study did 
not provide adequate time for individuals to complete the steps necessary to request access 
and/or training.  For example, completion of the Data Release Agreement (the first step in 
CRDW access) requires that the principal investigator for the intended project be MCW faculty.  
Individuals from other CTSI partner sites who attended the awareness presentations may have 
needed time to find an MCW collaborator and, therefore, may not have requested access during 
the study period. 
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Another possible explanation is that participants may have proactively attended the CRDW 
presentations to understand the availability of CRDW tools for future research that may not 
occur for months or years.  While participants were asked about their likelihood to use the 
CRDW before and after the presentation and the likelihood of use increased, they were not asked 
about their potential timelines for using the tools.  As a result, the BMI department may see an 
influx of access and/or training requests after this study as grant submission deadlines approach.  
Fortunately, because the schedule of presentations has been documented, requests could be 
monitored to determine if there is a spike after the study period. 
One further explanation is that the awareness presentation intervention provided sufficient 
information for participants to identify that the CRDW tools and/or data would not meet the 
needs of their current research projects.  In this scenario, an individual would not have 
immediately requested access or training for the CRDW, but may request access and/or training 
for future research projects.  This explanation is supported by the increase in the likelihood to 
use level identified in the post-assessments, but the lack of immediate increase in access and 
training requests for the CRDW.  
Limited historical data and lack of a standardized awareness process may also have affected the 
results for hypotheses H3 and H4.  The requests for CRDW access and training have been 
tracked since 2016.  As a result, only two growth rates exist for comparison (2016 to 2017 and 
2017 to 2018).  Because a significant spike in requests was tracked in 2017, the 2016-2017 
growth rates significantly increased.  To have a higher 2017-2018 growth rate, an even more 
significant spike in requests would need to occur in 2018.  If the large number of requests in 
2017 was an anomaly, comparing the growth rate from 2017-2018 to the growth rate from 
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2016-2017 may be misleading.  Without additional historical data, no conclusion can be drawn 
about a “typical” year-to-year growth rate.  Additionally, without a standardized process for 
raising awareness, no documentation exists of activities that may have affected the number of 
2017 requests.  Fortunately, as requests continue to be tracked, a retrospective review could be 
completed to review the number of requests year-to-year to determine typical growth rates.  As a 
result of this study, the BMI department also has documentation of when CRDW awareness 
presentations and training sessions occurred, and they could use this information to review 
changes in request rates after the study period. 
A final possible explanation is that the awareness presentation content was insufficient to move 
individuals from the knowledge stage to the persuasion stage.  While the content of the 
presentation was focused on factors found to be important in technology adoption, these factors 
and the approach to delivering the content were not confirmed with the target population prior to 
performing this study.  For example, although the presentation focused on the data available 
(which was identified as important for perceived usefulness and task compatibility), the actual 
content may have focused too much on specific data elements available and not on stories of how 
the available data had been used for research purposes (which may have been the focus desired 
by the target population).  As a result, the increase in knowledge and likelihood to use may have 
been insufficient to cause immediate requests for access and training. 
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6.3 Research Question #2:  Achievement of Outcomes Post-training 
For research question #2 (Q2), the goal was to determine if the CRDW training provided 
sufficient information for trainees to complete the CRDW activities related to their intended 
research outcomes.  Based on the results for research hypotheses H5 and H7, the training does 
increase knowledge of the CRDW and self-reported likelihood to use the CRDW.  Interestingly, 
training did not significantly change the number of potential outcomes identified by trainees 
(research hypothesis H6).  In addition, only 24% of the trainees completed the CRDW actions 
related to their intended research outcomes within 30 days of completing training (research 
hypothesis H8).  As a result, while the persuasion stage was reached, the decision stage was not 
reached during the study period. 
For research hypothesis H6, trainees were asked to identify their intended outcomes from using 
the CRDW.  The intended outcome options included protocol, poster presentation, grant 
submission, abstract, manuscript, and other.  Trainees were allowed to select one or more (up to 
a maximum of six) of these intended outcomes.  Within this study, no significant change in the 
number of intended outcomes existed between the pre-assessments and the post-assessments.  
One explanation is that trainees discovered (during training) that the CRDW would not be useful 
for their intended research projects.  This explanation is contradicted, though, by the likelihood 
to use indicated by the trainees, which increased from pre-assessment to post-assessment. 
To investigate this contradiction further, the intended outcomes selected in the pre-assessment 
and post-assessment by individual trainee were compared.  In addition, for each individual 
trainee, the likelihood to use value was compared between the pre- and post-assessment.  Finally, 
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a numeric change in level of likelihood to use was calculated.  For example, if a trainee indicated 
he/she was unsure about using the CRDW in the pre-assessment, and then indicated being very 
likely to use the CRDW in the post-assessment, this was a two-level change in likelihood to use 
(since the likelihood to use level increased by two).  Below are the results of this investigation. 
Table 16. Comparison of Intended Outcomes and Likelihood to Use 
Change in 
Likelihood to Use 
Number of 
Trainees 
Intended Outcomes 
Increased Stayed the Same Decreased 
Increased by two 
levels 
3  1 trainee 2 trainees 
Increased by one 
level 
5 1 trainee 3 trainees 1 trainee 
No change in 
likelihood to use 
8 2 trainees 6 trainees  
Decreased by one 
level 
1  1 trainee  
Totals 17 3 trainees 11 trainees 3 trainees 
 
Within these results, an interesting pattern occurs.  For trainees indicating a significant change in 
the likelihood to use the CRDW (two levels), the majority of trainees indicated fewer intended 
outcomes of CRDW use after training.  For trainees indicating a small change (one level) or no 
change in likelihood to use, the majority of trainees indicated the same number of intended 
outcomes in the pre- and post-assessment.  One explanation is that trainees with a significant 
change in likelihood to use were able to focus on a specific task they wanted to complete with 
the CRDW, so they reduced their number of intended outcomes as a result.   
Further research is needed to determine if this pattern continues to emerge with a larger group of 
trainees.  Additionally, future research should include questions to obtain qualitative information 
about the selection of intended outcomes, such as asking trainees about why they selected 
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specific outcomes.  The goal of this qualitative information would be to understand, more fully, 
the link between outcomes and likelihood to use.  Also, because the training pre- and post-
assessments were de-identified for this study, the study researcher was unable to correlate these 
findings with a trainee’s completion of activities within the CRDW.  For example, the study 
researcher could not determine if trainees with a significant change in likelihood and a lower 
number of intended outcomes completed the CRDW activities related to their intended research 
outcomes at a greater rate than other trainees.  Future research should identify the trainee in the 
pre- and post-assessments so that these results can be correlated with the results of reviewing 
audit trails of CRDW activity. 
For research hypothesis H8, only 24% of the trainees completed the CRDW actions related to 
their intended outcomes within 30 days of completing training instead of the hypothesized 50% 
or greater.  One of the most likely explanations for these results is the 30-day window for post-
training follow-up was insufficient based on the intended outcomes identified in the feasibility 
and/or data release agreements by the particular trainees involved.  Within these agreements, 
trainees could select one intended outcome of requesting access to the CRDW tools.  Of the 17 
trainees who participated, ten trainees (59%) identified creation of a manuscript as the intended 
outcome within their feasibility/data release agreements and seven (41%) identified “other” 
intended outcomes.  For those identifying other intended outcomes, most involved innovative 
quality improvement projects or investigation of new care models, which are significant 
undertakings.  For all but one trainee, the outcomes identified were linked to completion of a 
query (typically to identify an appropriate patient cohort) and then a data extraction (either to 
obtain data about specific patients or obtain identified patient information used for completion of 
chart review).  While most trainees (82%) completed the query activities within 30 days, only 
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four completed the data extraction within that timeline. Considering this timeline in the context 
of the intended outcomes, this timing is logical; teams may initially query to determine if a 
sufficient patient population exists to perform their studies, but then may need time to refine their 
research hypotheses and protocols before performing the data extraction.  These activities can be 
time-consuming and may not fit within a 30-day window.   
This explanation seems to be supported by the results from two of the components within this 
study.  First, within the 30-day post-training assessment, four of the ten respondents identified a 
neutral or agreement response to the “I lacked the time to effectively use the CRDW” statement, 
which may indicate that 30 days is insufficient time to begin working with CRDW tools.  In 
addition, one of the comments from this assessment identified that a trainee had not yet had the 
time to use the CRDW for his/her work.  Second, when reviewing one of the early trainee’s 
achievement of intended outcomes using audit trail data, the trainee completed the needed query 
within the 30 days post-training, but did not complete the extraction until three months later 
(which happened to be within the timeline of the audit trails obtained, but outside of the 30-day 
window for that particular trainee).  Fortunately, because the training dates for all of the 
participating trainees are known, CRDW activity could be reviewed at a later date to determine if 
a longer study period would change the results for the completion of CRDW activities. 
Further evidence for this explanation may be the lack of change in the number of potential 
outcomes identified by participants before and after training as part of the pre- and post-
assessments.  In creating the training assessment, a base assumption was that trainees would 
already have been planning to use the CRDW in every way possible to support their research, 
implying that trainees would query and extract all data from the CRDW.  As a result, the training 
129 
assessment measured only whether or not new research outcomes could be envisioned after 
training. 
A better approach may have been to gauge the trainee’s planned activities within the CRDW 
before and after training.  For example, a trainee may have identified using the CRDW for 
creation of a study protocol and grant submission.  Prior to starting training, this trainee may 
have intended to use the CRDW only to obtain cohort information.  However, during training, 
the trainee discovered the potential to extract some of the needed data from the CRDW.  While 
the potential outcome of using the CRDW would not change (still being a study protocol and 
grant submission), the intended activities to be performed in the CRDW may change.  
If trainees’ planned activities within the CRDW changed as a result of training, further evidence 
exists for the 30-day window being too short to assess outcome achievement.  In the above 
example, if the trainee discovered the potential to extract information from the CRDW, the 
trainee may also have had to reconsider his/her data gathering plans, which could require more 
than 30 days to complete. 
6.4 Research Question #3:  Factors Influencing CRDW Use 
For research question #3 (Q3), the goal was to explore potential factors that influence trainees’ 
use of the CRDW for clinical and translational research purposes, specifically within 30-45 days 
of their original training. 
Based on the findings for the previous research questions, time may be the most significant 
factor in CRDW use.  From the initial time to find an MCW collaborator to the time needed to 
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refine data gathering processes, trainees may “feel” that their existing processes require less time 
than this “new” technology. 
Ease of use may also be a factor (and may be correlated to the “time” factor).  Within the 30-day 
post-training follow-up assessment, the ease of use ratings by tool and the responses to the 
statement “Overall, I found the CRDW easy to use” were somewhat mixed.  Of the ten trainees 
completing the assessment, most agreed that the CRDW was easy to use.  Of the six trainees that 
had used the tool since training, three identified TriNetX, two identified i2b2, and one identified 
Honest Broker as difficult to use. However, caution was exercised in using the ease of use ratings 
to determine which tool(s) may be challenging.  In this section of the assessment, a “Did not use” 
option was originally planned, but was mistakenly omitted from the final assessment provided to 
all of the trainees.  Although only one trainee identified this issue in his/her comments on the 
assessment, it is unclear if the six trainees who responded to this question rated the ease of use 
based on experience or simply selected a rating to be allowed to complete the remainder of the 
assessment.  As a result, further investigation is required to determine if ease of use is a 
significant factor. 
The type of CRDW support available may also be a factor.  Currently, support is available by 
contacting the BMI Business Analyst.  Trainees that pursued this support provided positive 
comments within the 30-day post-training assessment.  Interestingly, two respondents who 
reported a lack of support did not contact the BMI department.  These respondents may have 
preferred another form of support (such as the ability to search online information about the 
CRDW or view tutorial videos).  As a future step, follow-up could occur with these trainees to 
determine if additional types of support would be a significant factor in use of the CRDW. 
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Finally, the data available within the CRDW may be a factor.  Of the ten trainees responding to 
the 30-day post-training assessment, four either agreed with or provided a neutral response to the 
statement “The data I needed was not available within the CRDW.”  Should the CRDW lack data 
needed for research, this may also explain why most trainees did not perform a data extraction 
from the CRDW and, therefore, did not achieve their intended outcomes as defined in study 
component #3 (objective measurement of outcomes). 
From the 30-day post-training assessment responses, training is not seen as a barrier to CRDW 
use, as all trainees felt that they received sufficient training. 
6.5 Implications of the Findings 
The purposes of this study were to identify interventions that increase research team awareness 
of data warehouses, to assess outcomes of data warehouse training, and to define objective 
measures for determining if research teams complete the data warehouse activities related to 
their intended research outcomes.  The following section discusses the implications of the study 
findings on achieving these purposes. 
The findings of this study indicate that an awareness presentation intervention can increase 
research team knowledge of the CRDW, as well as their self-reported likelihood to use.  This 
intervention alone does not appear to result in increased CRDW use within a 90-day period.  
Several implications can be derived from this finding.  First, this finding serves as an initial 
baseline that can be used for future research timelines.  Second, awareness interventions need to 
be tailored to the target population.  Failure to check the awareness presentation content and 
delivery with representatives from the target population may have reduced the effectiveness of 
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the intervention.  Finally, interventions should include an assessment item to understand the 
timeline that individuals have for pursing adoption of new technology.  For example, individuals 
who participated in this study’s presentations may have done so planning for research that they 
do not intend to pursue for several months.  Understanding these timelines is critical to refining 
two of the initial objective measurements within this study:  the number of access CRDW 
requests and the number of CRDW training requests. 
This study also found that a majority of trainees did not complete the CRDW activities related to 
their intended research outcomes within 30 days of receiving CRDW training.  Two key 
implications can be identified from this finding.  First, the definition of “outcome achievement” 
needs to be refined with assistance from the target population.  Within this study, the definition 
of “outcome achievement” was derived based on the experience of the key training and support 
individual for the CRDW.  While this definition is a sufficient baseline, the next step should be 
working with individuals from the target population to obtain their feedback on this definition 
and what they consider “outcome achievement” related to data warehouse use.  A second 
implication from this finding is that more research is needed to understand the timeline for 
trainees to complete activities post-training, as the 30-day window appears to be too short based 
on initial findings.  Additionally, the appropriate window may vary depending on the intended 
research outcomes identified by the trainee. 
Similar to other research using the conceptual frameworks that served as the basis of this study, 
time, ease of use, type of support, and availability of data appear to be potential factors 
influencing CRDW use and achievement of outcomes.  Future work is needed to understand the 
significance and correlation of these factors.  For example, future work could focus on the 
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creation of a predictive model with a target variable of actual CRDW use and predictor variables 
that are correlated to actual use such as time, ease of use, type of support, and availability of 
data.  Part of the model creation would be a calculation of the significance of each of these 
predictors within the model.  The significance of the predictive factors could then inform 
research to influence these predictors in order to increase actual use of the CRDW. 
From a research protocol perspective, this study provides new protocols that can serve as a 
foundation for objective measurement of technology use and adoption.  One of the limitations 
noted in research related to the technology adoption frameworks is the lack of objective 
measures for actual technology use, because most studies have focused on measurements of 
intention to use or likelihood to use.  Within this study, both the likelihood to use and actual use 
were measured using techniques that are common regardless of technology platform and can be 
used retrospectively or prospectively (as done in this study).  For example, while CTSA hubs 
may have chosen different data warehouse implementations, most will have some form of 
request process and audit trails.  The process used in this study can be easily adapted based on a 
CTSA hub’s specific technology implementation and used to review past and current activities 
within the data warehouse. 
Finally, the participation rates within this study were significantly higher than originally 
anticipated.  Several factors seemed to influence these rates.  First, the assessment tools were 
short and simple to complete.  For example, both the awareness presentation and training 
assessments were a page in length and included five questions or less.  Second, assessments 
occurred either during meetings or during a known timeframe (such as 30 days post-training).  
As a result, participants did not need to find additional time in their schedules and/or could plan 
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time within their schedules to complete the assessment.  Finally, the background and reason for 
each assessment were clearly described before participants agreed to complete the assessments.  
This information proved important in participation decisions, as several individuals directly 
expressed a desire to help with PhD research and/or assist in improving CRDW processes.  In 
future work, these factors should be considered when trying to assess potential participation 
rates. 
6.6 Study Finding Limitations 
Although this study has several strengths and contributes to closing the gaps identified within the 
literature corpus and practical implementation, several limitations of the findings need to be 
noted. 
First, the study period, especially the 30-day window for post-training follow-up, may have been 
too short to completely assess CRDW use.  Within this study, identifying that 30 days may be 
insufficient is an important finding, as no baseline previously existed.  An important next step in 
exploring this topic should be understanding the “typical” timeline for use of the CRDW within 
research projects. 
Second, although this study exceeded the proposed sample sizes and participation rates, the 
number of participants was still fairly small and did not include representation from all CTSI 
partner institutions.  This study was a first step in gathering information about CRDW use, but 
further work is needed to fully reflect the experience of all CTSI partners as well as other CTSA 
hubs. 
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Finally, improvements to the research methodology were identified.  For example, a question 
related to planned activities within the CRDW would have assisted in understanding of changes 
to trainees’ plans for using the CRDW within their research.  Additionally, refinement of the 
assessment item related CRDW tool ease of use is needed to gather more accurate information 
about perceived ease of use.  As a result, future research should incorporate these lessons learned 
to gain further knowledge. 
6.7 Future Research 
Based on the findings from this study, several areas of future work have been identified. 
 Future research needs to focus on refining the objective measurement of “outcome 
achievement.”  This research may include focus groups with the target population to refine 
the current definition, retrospective studies of audit trail data to obtain a timeline and baseline 
of outcome achievement, and replication of this process focusing on use of different 
technology platforms. 
 Research also needs to occur to better understand the timing of technology adoption.  This 
research may include interviews with individuals after awareness presentations to understand 
how likelihood to use is linked to the timeline for requesting access and/or training, studies 
identifying the typical time between access request and training request, and review of 
CRDW activity to determine the typical activity pattern that appears within audit trails (e.g., 
do most users access the tool once or multiple times and how much time elapses between 
uses). 
 Further research is needed to understand the significance and correlation of the factors 
influencing CRDW use.  This research may include extending this study to all CTSI partners 
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and/or replicating this study with other CTSA hubs and providing more detailed 
assessments/interviews specifically targeting significance and correlation. 
6.8 Conclusion 
Although significant research is being conducted about and with data warehouses for current and 
future clinical and translational science purposes, critical gaps exist within the literature corpus 
real-world implementation and practice.  This study focused on three of these gaps:  the need to 
identify interventions that increase research team awareness of data warehouses, the need to 
assess outcomes of data warehouse training, and the need to define objective measures for data 
warehouse activities related to research outcome achievement. 
To address these gaps, a study was conducted with the CTSI of Southeast Wisconsin focusing on 
use of the CRDW.  The study included an intervention to raise research team awareness of the 
CRDW, assessments of the awareness intervention and existing CRDW training, and definition 
and use of objective measures for completion of CRDW activities related to their intended 
research outcomes after CRDW training.  Four study components were included within the 
study, and these components were based on four conceptual frameworks related to adoption of 
technology and assessment of learning objectives: Diffusion of Innovation theory, Technology 
Acceptance Model, DeLone and McLean Information Systems Success Model, and Bloom’s 
Taxonomy of Educational Objectives.  
Key study findings suggest that the awareness intervention and training were successful in 
increasing research team knowledge of the CRDW and self-reported likelihood to use, but this 
increase did not result in a subsequent increase in CRDW access requests or training requests 
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within the study period.  In addition, only 24% of trainees completed the CRDW activities 
related to their intended research outcomes within 30 days of training.  The time needed for 
adopting the technology, the ease of use of the CRDW tools, the types of CRDW support 
available, and the data available within the CRDW may all be factors influencing these 
outcomes.   
Although several study limitations have been noted, this study provides important findings 
regarding attainment of technology knowledge and its links to actual technology use, the 
correlation between self-reported likelihood to use and actual technology use, the timeline of 
technology adoption, and foundational protocols for objective measurement of technology use 
and adoption.  Future research extending these findings should focus on refining the objective 
measurement of “outcome achievement,” understanding the timing of technology adoption, and 
measuring the significance and correlation of factors influencing CRDW use. 
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APPENDIX A: INSTITUTIONAL REVIEW BOARD APPROVAL LETTER 
The following pages show the institutional review board (IRB) approval letter for this project. 
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APPENDIX B: AWARENESS PRESENTATION CONTENT 
The following pages show the content covered during the awareness presentation (study 
component #1) for this research study.  The content and slides were developed by the BMI 
Business Analyst, Kristen Osinski, and reviewed by the study researcher. 
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APPENDIX C: AWARENESS PRESENTATION ASSESSMENT TOOL 
The following page shows the assessment tool used before and after the awareness presentation 
(study component #1). 
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APPENDIX D: CRDW TRAINING ASSESSMENT TOOL 
The following page shows the assessment tool used before and after the one-on-one/small group 
CRDW training (study component #2). 
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APPENDIX E: 30-DAY POST-TRAINING ASSESSMENT TOOL 
The following pages show the assessment tool used 30 days after training was received (study 
component #4).  Although participants had the option of completing this assessment via 
electronic survey or phone or in-person interview, the content of this assessment is shown as 
formatted for the electronic survey in REDCap (with section numbers and additional information 
added to describe the flow of the survey questions). 
Section #1:  Use of the CRDW Tools 
 
If the answer to the previous question is Yes, the following additional questions appear: 
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Section #2:  Requesting Support 
 
If the answer to the previous question is Yes, the following additional question appears: 
  
Section #3:  Benefits and Barriers to CRDW Use 
  
Section #4:  Likelihood to Use the CRDW 
 
Section #5:  Comments 
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tracking systems for individual departments, the Hematopoietic Progenitor Cell 
(HPC) Program, and the Diagnostic Laboratories business unit (such as document 
control, training, project management, resource tracking, change management, project 
life cycle, validation, equipment tracking, and quality control and monitoring). 
 Responsible for testing/validation of computer systems and applications, including 
the lab information system (Cerner) and the blood operating system (LifeTrak).  
 Responsible for daily quality activities, such as document creation and review; staff 
training; creation and tracking of metrics; identification and implementation of 
corrective actions; preparation of regulatory agency packets; facilitation of 
departmental, internal, and external audits; and completion of audit responses. 
 Responsible for creation and delivery of training such as Change Management, 
Advanced Microsoft Word Skills, Quality Basics, Project Administration, Effective 
Writing, and Statistical Techniques (Basic and Intermediate). 
Plexus Technology Group 1999 to 2001 
Neenah, WI 
 
Embedded Software Design Engineer 
 Responsible for the analysis, design, implementation, and testing of software for 
medical devices, safety systems, and datacom/telecom products. 
 Member of the Recruitment/Interview Team, the New Employee Training 
Committee, and the Software Diagnostics and Testing Focus Group. 
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Publications and Presentations 
 Impact of Awareness and Training on the Adoption of Clinical Research Data Warehouses.  
Katie McCarthy.  American Medical Informatics Association (AMIA) Informatics Educators 
Forum (IEF).  June 2019 (accepted). 
 Merging Farms:  Combining Two Instances of Epic.  Bradley Howard, Katie McCarthy, 
Kathy Patrino, and Michael Sura.  Epic Users’ Group Meeting.  September 2014. 
 Featured in Going from Epic to Epic:  One Health System’s Unique Journey.  Healthcare 
Informatics.  December 2013. 
 Cutover Planning and Implementation:  Keys to a Successful Go-live.  Katie McCarthy and 
Nanda Kothinti.  Epic Project Managers Advisory Council.  April 2013. 
 Do Computer-Aided Diagnosis Systems in Mammography Need to be Trained to Individual 
Observers? Charles Kahn, Katie McCarthy, and Elizabeth Burnside.  Radiological Society of 
North America (RSNA) Annual Meeting.  November 2005. 
Professional Affiliations 
 American Medical Informatics Association (AMIA) 2002 to present 
 American Society for Quality (ASQ) 2001 to present 
Certified Quality Improvement Associate (CQIA) 2003 to present 
Certified Software Quality Engineer (CQSE) 2002 to present 
 Association for Computing Machinery (ACM) 2000 to present 
 Healthcare Information and Management Systems Society (HIMSS) 2006 to present 
Honors 
 MSOE Falk Engineering Educator Award (finalist) 2014, 2015 
 MSOE Outstanding Mentor Award (nominee) 2000, 2002 
Community and Professional Involvement 
 MSOE Nursing Advisory Committee, Member 2017 to present 
 BloodCenter of Wisconsin (BCW) 2004 to present 
Lecturer for Specialist in Blood Banking (SBB) program 
 Third Coast Consortium for Biomedical and Health Informatics 2015 to 2017 
Co-organizer 
 HIMSS Dairyland Regional Networking event 2014 to 2017 
Co-organizer 
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Professional Development 
 Massachusetts Institute of Technology (MIT) 2016 
Professional development certificate:  Big Data and Social Analytics 
 Blackboard Learning Management System 2015 
Webinar:  The Ins and Outs of Designing Exemplary Courses 
 Massachusetts Institute of Technology (MIT) 2016 
Professional development course:  Tackling the Challenges of Big Data 
 ACM Computer-Human Interaction (CHI) conference 2014 
 Epic User Group Meeting (UGM) 2009, 2013, 2014 
 Epic Project Managers Advisory Council 2013 
 ASQ World Conference for Quality and Improvement 2006 
 Cerner Healthcare Conference 2004 
 MSOE Quality Engineer training 2004 
 ASQ Quality 101 training 2003 
 ASQ Software Quality Engineering training 2002 
